WO1996025897A2 - Covered expanding mesh stent - Google Patents

Covered expanding mesh stent Download PDF

Info

Publication number
WO1996025897A2
WO1996025897A2 PCT/US1996/002406 US9602406W WO9625897A2 WO 1996025897 A2 WO1996025897 A2 WO 1996025897A2 US 9602406 W US9602406 W US 9602406W WO 9625897 A2 WO9625897 A2 WO 9625897A2
Authority
WO
WIPO (PCT)
Prior art keywords
stent
mesh
expandable
polymer
configuration
Prior art date
Application number
PCT/US1996/002406
Other languages
French (fr)
Other versions
WO1996025897A3 (en
Inventor
Robert S. Bley
Kevin H. Van Bladel
Joseph R. Thomas
Original Assignee
Menlo Care, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Menlo Care, Inc. filed Critical Menlo Care, Inc.
Priority to AU49296/96A priority Critical patent/AU719980B2/en
Priority to CA002213403A priority patent/CA2213403C/en
Priority to EP96905567A priority patent/EP0810845A2/en
Publication of WO1996025897A2 publication Critical patent/WO1996025897A2/en
Publication of WO1996025897A3 publication Critical patent/WO1996025897A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2/07Stent-grafts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08Materials for coatings
    • A61L31/10Macromolecular materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/0077Special surfaces of prostheses, e.g. for improving ingrowth
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2/07Stent-grafts
    • A61F2002/072Encapsulated stents, e.g. wire or whole stent embedded in lining
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2/07Stent-grafts
    • A61F2002/075Stent-grafts the stent being loosely attached to the graft material, e.g. by stitching
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/0067Means for introducing or releasing pharmaceutical products into the body

Definitions

  • This invention relates generally to the field of stents for use primarily in ducts and vessels of the body, and more particularly, to the area of expandable stents which expand and/or reconform after implantation in the body.
  • a number of biomedical devices have been used for the stenting of body passages that have become blocked or are otherwise damaged, or weakened. Expanding stents seem the most promising for this purpose because of the advantages provided by insertion of a small diameter tube-like device and the ultimate enlargement of the diameter to accommodate the flow of body fluids or food and the increase in time prior to occlusion of the stent.
  • expandable meshes which includes self-expanding types and non-self-expanding types
  • non-expandable stents which are typically made of plastic or polymeric material.
  • the self-expanding meshes can be made of a material, such as Nitinol, which changes configuration upon heating to body temperature.
  • Other self-expanding meshes are made of resilient mesh material which can be flexed down into a small diameter tube and held in place in such a configuration until it is released, at which time it expands to a larger diameter configuration.
  • the non-self-expanding meshes are expanded by use of an inflatable balloon which is placed inside the mesh in a small diameter configuration, and then inflated, thereby expanding the mesh to a larger diameter configuration. The balloon is then deflated for removal, leaving the mesh in its expanded configuration.
  • the expandable metal mesh stents are particularly advantageous in that they can increase in size up to 36 Fr.
  • the metal meshes are difficult to remove since tissue in-growth occurs over time.
  • a number of other problems, for example, mucosal hyperplasia, fungal proliferation, or neoplasm also are common with expandable metal mesh stents.
  • the expandable mesh stents can be made in a variety of materials such as, for example, stainless steel.
  • the expandable mesh stents can be made in a variety of configurations such as a coiled spring, a variety of zig-zag patterns including various stents knows as "Z" stents, braided filament, and other collapsible configurations.
  • One type of expandable stent comprises a cylindrical member having a slit cut along its length, so that the edges along the length can overlap to allow for compression to a reduced size.
  • a further configuration which may be described as a perforated tube comprises a generally rigid tube with openings cut therein to allow for radial expansion under force of an expansion balloon or by expansion due to heating.
  • the expandable mesh stents can be braided, woven, knitted, formed, molded, machined or made by other methods known in the art.
  • Various mesh designs are disclosed, for example, in U.S. Patent Nos. 4,512,338, 4,503,569, 4,922,905, 4,733,665, 4,950,227, 5,089,006 and 5,061 ,275.
  • Other materials, configurations and methods of manufacture in addition to those described above are known.
  • expandable mesh is meant to include, without limitation, self-expanding and non-self-expanding configurations made of any generally rigid or springy material which when expanded have an open network or arrangement which would otherwise allow tissue in-growth, and would not otherwise prevent fluid flow through its walls.
  • these prior art mesh stents have been utilized with a polymeric sheath or cover; however, since these sheaths must be stretched to increase in size, they exert a force that resists expansion, which tends to limit the final expanded size of the mesh. Additionally, this resistance may make expansion more problematic.
  • the sheath may be folded or bundled over the mesh when it is compressed, so that no force is exerted upon expansion. However, this method increases the size of the compressed stent, so that a larger size catheter is required for a given size stent.
  • plastic or polymeric stents exist only in smaller sizes because of the difficulty of inserting a larger catheter through the channel of existing scopes or in narrow body passages, such as veins or arteries, bile ducts, the esophagus, prostate, and the like.
  • a disadvantage of the plastic stents is that as a result of the smaller size of the lumen, the plastic stents occlude faster than the expandable stents.
  • One advantage of plastic or polymeric stents is that their closed structure prevents tissue in-growth which therefore makes it easier to remove, and less likely to be occluded by tissue in-growth from the outside.
  • the tubular body may comprise a flexible material where the diameter can be changed between a small diameter for insertion, and a final, expanded diameter after placement allowing for fluid flow therethrough.
  • the self-expanding device assumes its final, expanded configuration when in an unrestricted condition, free of external forces in the radial direction.
  • These type of devices must be compressed and loaded into a sheath that restrains the device radially for insertion into the body via a catheter. After insertion, the sheath or loading system may be removed to allow for expansion. After removal of the sheath, the device expands to its final diameter under spring-like forces resulting from the compression.
  • the stent takes on its expanded shape after it is heated above its transition temperature.
  • the final expanded configuration is achieved.
  • other methods of expansion and contraction are known.
  • the expandable stent should eliminate or minimize tissue in ⁇ growth without requiring a covering which either resists expansion or which must be folded or bundled when the stent is in the small radius, non-expanded condition. Further, it is desirable in some situations that the expandable stent does not require a loading sheath, so that a smaller sized catheter can be used to insert the stent into the body.
  • the present invention comprises an expandable mesh with an expandable polymer layer which can be on the inside of the expandable mesh stent, on the outside of the expandable mesh stent, within the interstices of the expandable mesh stent, or any combination of inside, outside and within the interstices of the mesh stent.
  • the expandable polymer does not require either stretching or folding, nor does it exert a significant resistance to expansion.
  • the present invention may be used in a number of different fields of medicine: products may include expandable biliary, vascular, endotracheal, esophageal, and prostatic devices. The size and design may be different for each medical application.
  • the polymer is expandable by hydration.
  • the polymer may be a member of the family of polymers sold under the trademarked name AQUAVENE®, examples of which are described in U.S. Patent Nos. 4,883,699 and 4,911 ,691.
  • Other expandable polymers which expand by hydration known in the art include HYPAN® (Hydrolyzed polyacrylonitrile) (U.S. Patent No. 4,480,642), hydrophilic polyether polyurethane (U.S. Patent No. 4,798,876), polyurethane diacrylate (U.S. Patent No.
  • hydrogels including cross-linked PVP (polyvinyl pyrrolidone), PVA (polyvinyl alcohol), PEO (polyethylene oxide) and pHEMA (poly (hydroxyethyl methacrylate)).
  • PVP polyvinyl pyrrolidone
  • PVA polyvinyl alcohol
  • PEO polyethylene oxide
  • pHEMA poly (hydroxyethyl methacrylate)
  • the hydrophilic polymer AQUAVENE® comprises a combination of a non-hydrophilic component (e.g., an elastomer such as urethane, silicone, PVC or the like) and a hydrophilic component (a hydrogel) which allows the material to swell and increase in size and maintain strength as outlined, for example, in U.S. Patent No. 4,883,699.
  • a non-hydrophilic component e.g., an elastomer such as urethane, silicone, PVC or the like
  • a hydrophilic component a hydrogel which allows the material to swell and increase in size and maintain strength as outlined, for example, in U.S. Patent No. 4,883,699.
  • the amount of expansion of the polymer is approximately equivalent to the amount of expansion of the mesh in the expanded condition.
  • the amount of expansion of a material or device may be described by the expansion ratio. For the mesh, this may be the ratio of, for example, the diameter in the compressed condition to the diameter in the unre
  • the expansion ratio may be the ratio of the diameter in the non-hydrated state to the diameter in the fully hydrated state.
  • the ratio of hydrophilic to non-hydrophilic component controls the amount of expansion of the material upon hydration, so that the amount of polymer expansion can be matched with the amount of expansion of the mesh.
  • the elastomer content should generally be in the range of approximately 15-75%, and preferably 20-65%, and more preferably 25-30% by volume in the dry (non-hydrated) state.
  • the polymer comprises a material which, by virtue of its method of manufacture, or, e.g., arrangement of the knit, may expand between a first, smaller configuration and a second, larger configuration without requiring stretching of the material to the larger configuration, so that the polymer can be expanded without offering significant resistance.
  • the material does not require folding or bunching to be placed in the smaller configuration, so that the presence of the material does not significantly increase the size of the compressed stent or reduce the size of the lumen.
  • One advantage of the present invention is the elimination of the open mesh of the prior art. The closed smooth surface of the polymer prevents tissue and tumor in-growth and allows for easier removal of the prosthesis.
  • the polymeric materials also self-expand, and can be devised to expand approximately the same degree as the open mesh.
  • the polymer can change from a small configuration to a larger configuration without significant resistance.
  • An advantage of the present invention relative to the use of the above described self-expandable polymers alone is that the expandable mesh provides a resistance to crushing which is much greater than the resistance to crushing of the polymer alone if the polymer formulation were such that it would expand as much as the mesh.
  • the structure of polymeric stents of self-expandable polymer which resist crushing may require excessively thick walls, which would either defeat the purpose of attempting to make the outside diameter as small as possible for easy insertion, or alternatively, make the internal diameter very small thereby defeating the purpose of using the stent to allow a larger volume of fluid to pass through the duct.
  • the expandable mesh of the present invention provides the mechanical strength necessary to prevent occlusion due to lateral forces such as from tumor growth.
  • additives may include, for example, antibacterial, anti-microbial, anti-calcification, growth hormones, anti-cancer-related drugs, anti-thrombogenic agents, and anti-restenosis agents which are beneficial in conjunction with, or in addition to the implantation of the stent.
  • the present invention still has the advantage of the expandable meshes which allow for the implantation of smaller prosthesis which thereafter increase in lumen size after insertion for greater flow rate, and longer implantation time prior to occlusion.
  • the design of the expandable mesh may consist of any type of self-expanding meshes such as those described in the above- mentioned patents.
  • the mesh may be a self-expandable mesh capable of collapsing to a smaller diameter and expanding if it is not held radially by a sheath, or in the case of heat-sensitive materials, until the temperature rises above the transition temperature of the material.
  • the expandable mesh may also be of the non-self expanding type which requires a separate force, typically an expansion balloon, to cause the expansion.
  • the expandable hydrophilic polymer holds the expanding mesh until the hydrophilic component of the polymer hydrates inside the body.
  • the polymer after hydration softens, swells, and expands to allow the contracted mesh to expand.
  • some expandable configurations of non-hydrophilic polymers have a structure such that they can change between a small to a large configuration without significant resistance and without folding or bunching in the small configuration. Under such circumstances, these polymers can be expanded along with the expandable mesh, either under the force of expansion from the mesh and/or under pressure from an expansion balloon.
  • Figure 1 is a sectional view of an embodiment of the present invention in collapsed condition.
  • Figure 2 is a sectional view of the embodiment of the present invention of Figure 1 in an expanded condition.
  • Figure 3 is a perspective view of the embodiment of the present invention of Figure 1 and 2.
  • Figure 4 is a perspective view of a further embodiment of the present invention.
  • Figure 5 is a perspective view of a further embodiment of the present invention.
  • Figure 6 is a view of a sectional view of a further embodiment of the present invention.
  • Figure 7 is a view of a portion of the embodiment of Figure 6.
  • the present invention comprises a stent or other medical generally tube-like device for implantation in the body on a temporary, semi-permanent or permanent basis, the invention comprising an expandable mesh with an expandable polymer layer on the inside of the mesh stent, on the outside of the mesh stent, within the interstices of the mesh stent or any combination thereof.
  • an embodiment of the present invention comprises a tubular shaped stent 10 comprising a mesh 12 and an outer layer 14.
  • the outer layer 14 covers all or most of the outer surface of mesh 12.
  • the layer 14 is shown only at the top and bottom edges of the Figure for purposes of illustration to allow viewing of mesh 12.
  • outer layer 14 is a sheath-like structure which may be attached to the mesh 12 in a variety of ways as discussed later.
  • a retention flange 16, or other mechanism, such as exposed wires, may be provided, to assist in maintaining the positioning of the structure after placement in the body, as is known in the prior art.
  • Figure 1 shows the stent in a collapsed position which is useful for initial insertion of the stent into the body.
  • the present invention 10 is now shown in its expanded condition. It still comprises mesh 12 and an outer layer 14, again shown only at the top and bottom edges of Figure 2 for purposes of illustration.
  • the stent 10 may have been inserted into a duct in the body from which outer layer 14 has absorbed water and expanded. The outer layer 14 upon expansion, no longer holds mesh 12 in the collapsed position, so that it too expands to the configuration shown in Figure 2.
  • FIG. 3 shows expanded stent 10 in perspective view. As can be seen, the mesh 12 is substantially completely covered by outer layer 14.
  • FIG 4 shows an alternative embodiment of the present invention.
  • stent 40 comprises mesh 42 and inner layer 44.
  • Inner layer 44 is similar to layer 14 of Figures 1 -3, with the exception that it is disposed within the mesh 42.
  • the stent 40 may have retention flange 46, or similar mechanism.
  • Figure 5 shows a further alternative embodiment of the present invention.
  • stent 50 comprises mesh 52, outer layer 54a and inner layer 54b.
  • a portion of outer layer 54a is cut-away for purposes of illustration for viewing of mesh 52, and inner layer 54b within mesh 52.
  • the outer and inner layers 54a and 54b are similar to layer 44 of Figure 4, and layer 14 of Figures 1 -3.
  • Figure 6 shows a sectional view of stent 60.
  • stent 60 comprises a mesh 62 with polymer 64 disposed within the interstices of mesh 62.
  • stent 60 may have a retention flange or other means to hold the stent in place within the body.
  • the polymer 64 is similar to the layers 54, 44 and 14 of the previous embodiments, with the exception, instead of being sheath-like as in layers 14 and 54a, or liner-like as in layers 44 and 54b, the layer 64 is now disposed within the interstices of mesh 62.
  • an interstitial layer is formed in conjunction with an inner layer, an outer layer, or both.
  • Figure 7 shows a portion of the stent 60 of Figure 6.
  • a number of materials may be used for the expandable mesh, such as stainless steel, tantalum, gold, titanium, nitinol heat sensitive material, or any suitable plastic material that may be formed so it may be collapsed, and when released, expand radially.
  • the expandable mesh may be self-expanding. Alternatively, the mesh may not be self- expanding, which would require external, or more typically, internal assistance, usually in the form of an expansion balloon.
  • the mesh may be any configuration and may be made in any manner, such as is disclosed in the earlier cited patents.
  • the polymer layers, such as layers 14, 44, 54a, 54b and 64 of the present invention may be one of the earlier described hydrophilic polymers, which expand upon hydration.
  • these layers may be made of a material which expands from a first, smaller configuration to a second, larger configuration, without requiring stretching and without exerting significant force against expansion. Further, the material does not require folding or bunching to contract from the expanded, larger configuration to the smaller configuration.
  • One material which has this property is expanded polytetrafluoroethylene (PTFE).
  • PTFE polytetrafluoroethylene
  • expanded PTFE is fabricated by pulling or expanding the PTFE after extrusion so that the PTFE is expanded in a longitudinal direction.
  • the expanded PTFE has the above-described property of being capable of being “pushed” and “pulled” between a shorter and longer length, without requiring stretching, or exerting significant resistance against expansion when going from the shorter to the longer length, and without requiring folding or bunching of the PTFE when being pushed into the shorter length from the longer length.
  • the PTFE may be radially expanded after extrusion.
  • the radially expanded PTFE may be used, for example, as the layer 14 of Figures 1 and 2.
  • the PTFE layer 14 may be placed on the mesh 12 in the configuration shown in Figure 1 , without requiring folding or bunching of the material 14, and then expand to the configuration shown in Figure 2, without offering significant resistance, and without limiting the final expanded diameter.
  • longitudinally expanded PTFE may be used provided it is disposed on the mesh 12 such that its direction of expansion is radial.
  • a length of longitudinally expanded PTFE may be cut and wrapped around an expandable mesh 12 with the longitudinal direction perpendicular to the length of the mesh.
  • the expanded PTFE may be desirable in comparison to a hydrophilic polymer layer when mesh 12 is non-self-expanding, since the mesh 12 can be expanded by an expansion balloon, without any significant resistance from the polymer layer during expansion.
  • the structure of the material should be such that the material has the above-described ability to assume a small, compressed configuration and a larger expanded configuration, without requiring stretching to the larger configuration, and without requiring folding to the smaller configuration.
  • the material may have this property by virtue of a weave or structure in which the fibers or filaments of the material are not aligned substantially longitudinally in the direction of expansion. In this way the material has some range of movement where the fibers or filaments of the material move in an accordion or bellows-like fashion.
  • the expansion ratio of the material may be described as, for example, the ratio of the expanded diameter to the compressed diameter, where the compressed diameter is the diameter at which the material is compressed to its smallest size without requiring folding or bunching on a large scale, and the expanded diameter is the diameter when the material has been expanded as far as possible without stretching. It will be appreciated that a material such as expanded PTFE, or other materials as described herein, may expand beyond this, but stretching would be required.
  • a preferred material to use for holding the mesh in a collapsed position, until insertion in the body where it allows the mesh to expand is a hydrophilic polymer such as that sold under the tradename AQUAVENE®.
  • An AQUAVENE® polymer is a co-continuous blend of a non-hydrophilic polymer (elastomer) and a hydrophilic polymer (hydrogel).
  • the hydrophilic component is generally in the range of approximately 15-75%, preferably 20-65% and more preferably 25-30%, by volume in the dry (non-hydrated) state. Some amount of the non-hydrophilic component is desirable to provide some physical integrity of the polymer sufficient for the purposes of the present invention. However, a cross-linked hydrogel alone can be used.
  • the mesh provides a greater crush resistance than a hydrophilic polymer of the same expansion ratio
  • the hydrophilic polymer provides some crush resistance, so that the present invention provides enhanced crush resistance as compared with either the mesh alone or the polymer alone.
  • the stent of the present invention may be formed by a number of different techniques in a number of different configurations.
  • a hydrophilic polymer layer in the form of a sheath, may be bonded to the expandable mesh in its collapsed position so that the "dry" polymer holds the expandable mesh in a collapsed state.
  • the polymer may be laminated, imbedded, coated, extruded, incorporated, or molded around the expandable mesh in its collapsed condition. Upon hydration inside the body, the polymer expands and looses its ability to restrain the expandable mesh, allowing the mesh to expand radially. In some cases, it may be necessary to allow the polymer to move relative to the expandable mesh.
  • a polymer in the form of a sheath placed external and/or internal to the expandable mesh which is not bonded to or embedded within the mesh, so that the polymer does not bind the filaments of the mesh, thereby preventing it from fully expanding.
  • the polymer may be so bonded or embedded, as the polymer in the hydrated state allows for sufficient movement of the filaments of the mesh to allow it to self expand.
  • the polymer layer of an embodiment using expanded PTFE or similar material may be coupled to the mesh using the above techniques. However, this type of polymer by itself will not hold the mesh in the collapsed configuration.
  • the expandable polymer layer or layers are designed such that they have an approximately equal expansion ratio as the expandable mesh.
  • the expandable polymer does not in any way resist the expansion of the expandable mesh, allowing for full expansion of the mesh. It will be appreciated that there may be a slight mismatch in expansion ratios without significantly affecting the performance of the device.
  • the expansion ratio of the hydrophilic polymer may be provided such that it assists in the expansion of the mesh.
  • the hydrophilic polymer may have a slightly greater expansion ratio, which may enable some meshes to expand to a slightly larger size than the mesh would expand without the presence of the hydrophilic polymer.
  • the polymer layer may be placed externally, internally within the interstices of the mesh, or any combination thereof.
  • the placement of polymers interstitially may be achieved in conjunction with an external or internal layer.
  • One preferred embodiment is to form the polymer both internal and external to the mesh in its collapsed position, so that the stent has a smooth inner lumen and a smooth outer surface. The smooth outer surface allows for easier removal of the stent, while a smooth inner surface may be helpful in increasing the time until occlusion occurs.
  • the polymer may expand through the mesh to some extent, so that a single polymer layer either internal or external, may provide a smooth surface both internal and external of the mesh.
  • an advantage of embodiments using a hydrophilic polymer which forms a hydrogel is that the hydrogel is typically highly biocompatible.
  • the existing self-expanding meshes must be pre-loaded in a sheath delivery system, which holds the mesh in a tight configuration.
  • the present invention may eliminate the need for a sheath in some cases, since the hydrophilic polymer of the present invention restricts the mesh in a collapsed position until after insertion and until the polymer is sufficiently hydrated. This arrangement can allow for a smaller external diameter delivery system than if a sheath is necessary, because the additional diameter of the sheath becomes unnecessary since its function is undertaken by the polymer. In some cases, if the polymer hydrates too quickly a sheath may be necessary to allow placement of the stent prior to hydration.
  • a coating could be applied to the polymer layer to slow down the hydration.
  • the coating may be similar to a material used to make time release drugs, or absorbable sutures.
  • the coating may be designed to take any desired predetermined amount of time to dissolve, to allow for any desired amount of time in which to place and maneuver the stent in the body.
  • suitable materials see, for example, Barrows, Thomas H., "Synthetic Bioabsorbable Polymers," in High Performance Biomaterials. M. Szycher, ed. 1991 , pp. 243 - 257.
  • the polymer layer may be a hydrophilic polymer, or may be an expandable polymer that expands without stretching, such as expanded PTFE. Additionally, the layer may be internal, and/or external, and/or interstitial. It will be appreciated that in an embodiment having more than a single layer, one or more of the layers may be a hydrophilic polymer and one or more of the layers may be a material such as expanded PTFE, if desired. Such an embodiment may be useful for delaying hydration for some period, so that the stent may be placed. For example, one or more hydrophilic layers may be disposed internal, and/or external, and/or interstitial of the mesh stent. An expanded PTFE layer, for example, may then be placed internal and/or external to any hydrophilic polymer layers to delay hydration.
  • products may include expandable biliary, vascular, endotracheal, esophageal, and prostatic devices.
  • the size and design may be different for each medical application.

Abstract

The present invention is a medical device such as a stent in the form of an expandable mesh with an expandable polymer layer thereon. The mesh is metal or plastic. The polymer may be any of a variety of expandable polymers, which either expand upon hydration, or expand without significant resistance. The invention may be used, for example, as an expandable biliary, vascular, endotracheal, esophageal, or prostatic device.

Description

COVERED EXPANDING MESH STENT
BACKGROUND OF THE INVENTION
1 . FIELD OF THE INVENTION :
This invention relates generally to the field of stents for use primarily in ducts and vessels of the body, and more particularly, to the area of expandable stents which expand and/or reconform after implantation in the body.
2. ART BACKGROUND:
A number of biomedical devices have been used for the stenting of body passages that have become blocked or are otherwise damaged, or weakened. Expanding stents seem the most promising for this purpose because of the advantages provided by insertion of a small diameter tube-like device and the ultimate enlargement of the diameter to accommodate the flow of body fluids or food and the increase in time prior to occlusion of the stent.
There are a number of different types of devices for stenting of body passages that may be classified into two general categories: namely, expandable meshes which includes self-expanding types and non-self-expanding types, and non-expandable stents which are typically made of plastic or polymeric material. The self-expanding meshes can be made of a material, such as Nitinol, which changes configuration upon heating to body temperature. Other self-expanding meshes are made of resilient mesh material which can be flexed down into a small diameter tube and held in place in such a configuration until it is released, at which time it expands to a larger diameter configuration. The non-self-expanding meshes are expanded by use of an inflatable balloon which is placed inside the mesh in a small diameter configuration, and then inflated, thereby expanding the mesh to a larger diameter configuration. The balloon is then deflated for removal, leaving the mesh in its expanded configuration.
The expandable metal mesh stents are particularly advantageous in that they can increase in size up to 36 Fr. However, the metal meshes are difficult to remove since tissue in-growth occurs over time. A number of other problems, for example, mucosal hyperplasia, fungal proliferation, or neoplasm also are common with expandable metal mesh stents.
The expandable mesh stents can be made in a variety of materials such as, for example, stainless steel. The expandable mesh stents can be made in a variety of configurations such as a coiled spring, a variety of zig-zag patterns including various stents knows as "Z" stents, braided filament, and other collapsible configurations. One type of expandable stent comprises a cylindrical member having a slit cut along its length, so that the edges along the length can overlap to allow for compression to a reduced size. A further configuration which may be described as a perforated tube comprises a generally rigid tube with openings cut therein to allow for radial expansion under force of an expansion balloon or by expansion due to heating. The expandable mesh stents can be braided, woven, knitted, formed, molded, machined or made by other methods known in the art. Various mesh designs are disclosed, for example, in U.S. Patent Nos. 4,512,338, 4,503,569, 4,922,905, 4,733,665, 4,950,227, 5,089,006 and 5,061 ,275. Other materials, configurations and methods of manufacture in addition to those described above are known.
As used herein, the term "expandable mesh" is meant to include, without limitation, self-expanding and non-self-expanding configurations made of any generally rigid or springy material which when expanded have an open network or arrangement which would otherwise allow tissue in-growth, and would not otherwise prevent fluid flow through its walls. Several of these prior art mesh stents have been utilized with a polymeric sheath or cover; however, since these sheaths must be stretched to increase in size, they exert a force that resists expansion, which tends to limit the final expanded size of the mesh. Additionally, this resistance may make expansion more problematic. Alternatively, the sheath may be folded or bundled over the mesh when it is compressed, so that no force is exerted upon expansion. However, this method increases the size of the compressed stent, so that a larger size catheter is required for a given size stent.
The plastic or polymeric stents exist only in smaller sizes because of the difficulty of inserting a larger catheter through the channel of existing scopes or in narrow body passages, such as veins or arteries, bile ducts, the esophagus, prostate, and the like. A disadvantage of the plastic stents is that as a result of the smaller size of the lumen, the plastic stents occlude faster than the expandable stents. One advantage of plastic or polymeric stents is that their closed structure prevents tissue in-growth which therefore makes it easier to remove, and less likely to be occluded by tissue in-growth from the outside. Some plastic or polymeric stents, as mentioned above, are simply small tubes.
With the current self-expandable mesh stents, the tubular body may comprise a flexible material where the diameter can be changed between a small diameter for insertion, and a final, expanded diameter after placement allowing for fluid flow therethrough. In some cases the self-expanding device assumes its final, expanded configuration when in an unrestricted condition, free of external forces in the radial direction. These type of devices must be compressed and loaded into a sheath that restrains the device radially for insertion into the body via a catheter. After insertion, the sheath or loading system may be removed to allow for expansion. After removal of the sheath, the device expands to its final diameter under spring-like forces resulting from the compression. In the case of heat sensitive materials, the stent takes on its expanded shape after it is heated above its transition temperature. With non-self- expanding mesh stents, upon expansion by the use of, for example, an expansion balloon, the final expanded configuration is achieved. Additionally, other methods of expansion and contraction are known.
What is needed is an expandable stent that allows for easy insertion and that increases in size to increase the time for occlusion to occur. The expandable stent should eliminate or minimize tissue in¬ growth without requiring a covering which either resists expansion or which must be folded or bundled when the stent is in the small radius, non-expanded condition. Further, it is desirable in some situations that the expandable stent does not require a loading sheath, so that a smaller sized catheter can be used to insert the stent into the body.
SUMMARY OF THE INVENTION
The present invention comprises an expandable mesh with an expandable polymer layer which can be on the inside of the expandable mesh stent, on the outside of the expandable mesh stent, within the interstices of the expandable mesh stent, or any combination of inside, outside and within the interstices of the mesh stent. The expandable polymer does not require either stretching or folding, nor does it exert a significant resistance to expansion.
The present invention may be used in a number of different fields of medicine: products may include expandable biliary, vascular, endotracheal, esophageal, and prostatic devices. The size and design may be different for each medical application.
In one embodiment of the present invention, the polymer is expandable by hydration. For example, the polymer may be a member of the family of polymers sold under the trademarked name AQUAVENE®, examples of which are described in U.S. Patent Nos. 4,883,699 and 4,911 ,691. Other expandable polymers which expand by hydration known in the art include HYPAN® (Hydrolyzed polyacrylonitrile) (U.S. Patent No. 4,480,642), hydrophilic polyether polyurethane (U.S. Patent No. 4,798,876), polyurethane diacrylate (U.S. Patent No. 4,424,305), and various hydrogels, including cross-linked PVP (polyvinyl pyrrolidone), PVA (polyvinyl alcohol), PEO (polyethylene oxide) and pHEMA (poly (hydroxyethyl methacrylate)).
The hydrophilic polymer AQUAVENE® comprises a combination of a non-hydrophilic component (e.g., an elastomer such as urethane, silicone, PVC or the like) and a hydrophilic component (a hydrogel) which allows the material to swell and increase in size and maintain strength as outlined, for example, in U.S. Patent No. 4,883,699. In a preferred embodiment the amount of expansion of the polymer is approximately equivalent to the amount of expansion of the mesh in the expanded condition. The amount of expansion of a material or device may be described by the expansion ratio. For the mesh, this may be the ratio of, for example, the diameter in the compressed condition to the diameter in the unrestricted, expanded condition. For the polymer layer, the expansion ratio may be the ratio of the diameter in the non-hydrated state to the diameter in the fully hydrated state. In the case of AQUAVENE®, the ratio of hydrophilic to non-hydrophilic component controls the amount of expansion of the material upon hydration, so that the amount of polymer expansion can be matched with the amount of expansion of the mesh. Under a currently preferred embodiment of the present invention, the elastomer content should generally be in the range of approximately 15-75%, and preferably 20-65%, and more preferably 25-30% by volume in the dry (non-hydrated) state.
In an alternative embodiment of the present invention, the polymer comprises a material which, by virtue of its method of manufacture, or, e.g., arrangement of the knit, may expand between a first, smaller configuration and a second, larger configuration without requiring stretching of the material to the larger configuration, so that the polymer can be expanded without offering significant resistance. Further, the material does not require folding or bunching to be placed in the smaller configuration, so that the presence of the material does not significantly increase the size of the compressed stent or reduce the size of the lumen. One advantage of the present invention is the elimination of the open mesh of the prior art. The closed smooth surface of the polymer prevents tissue and tumor in-growth and allows for easier removal of the prosthesis. It is recognized that there has been some use in the field of expandable meshes combined with polymeric materials which must stretch to expand as described earlier. However, in accordance with one embodiment of the present invention, the polymeric materials also self-expand, and can be devised to expand approximately the same degree as the open mesh. In accordance with a further embodiment, the polymer can change from a small configuration to a larger configuration without significant resistance. Thus, unlike prior art devices which either do not have any polymer layer, or which have a polymer layer which stretches with some resistance, the present invention allows for expansion of the mesh with no substantial resistance. It will be recognized however, that even if there is a small amount of resistance by the polymer, it may be within the spirit and scope of the present invention.
An advantage of the present invention relative to the use of the above described self-expandable polymers alone is that the expandable mesh provides a resistance to crushing which is much greater than the resistance to crushing of the polymer alone if the polymer formulation were such that it would expand as much as the mesh. The structure of polymeric stents of self-expandable polymer which resist crushing may require excessively thick walls, which would either defeat the purpose of attempting to make the outside diameter as small as possible for easy insertion, or alternatively, make the internal diameter very small thereby defeating the purpose of using the stent to allow a larger volume of fluid to pass through the duct. The expandable mesh of the present invention provides the mechanical strength necessary to prevent occlusion due to lateral forces such as from tumor growth.
Another advantage of the present invention is the ability to load additives into the hydrophilic polymer which may be released at a controlled rate. The additives may include, for example, antibacterial, anti-microbial, anti-calcification, growth hormones, anti-cancer-related drugs, anti-thrombogenic agents, and anti-restenosis agents which are beneficial in conjunction with, or in addition to the implantation of the stent.
In addition, the present invention still has the advantage of the expandable meshes which allow for the implantation of smaller prosthesis which thereafter increase in lumen size after insertion for greater flow rate, and longer implantation time prior to occlusion.
The design of the expandable mesh may consist of any type of self-expanding meshes such as those described in the above- mentioned patents. The mesh may be a self-expandable mesh capable of collapsing to a smaller diameter and expanding if it is not held radially by a sheath, or in the case of heat-sensitive materials, until the temperature rises above the transition temperature of the material. In some embodiments, the expandable mesh may also be of the non-self expanding type which requires a separate force, typically an expansion balloon, to cause the expansion.
In an embodiment of the invention, the expandable hydrophilic polymer holds the expanding mesh until the hydrophilic component of the polymer hydrates inside the body. The polymer after hydration softens, swells, and expands to allow the contracted mesh to expand. In alternative embodiments, some expandable configurations of non-hydrophilic polymers have a structure such that they can change between a small to a large configuration without significant resistance and without folding or bunching in the small configuration. Under such circumstances, these polymers can be expanded along with the expandable mesh, either under the force of expansion from the mesh and/or under pressure from an expansion balloon.
BRIEF DESCRIPTION OF THE DRAWINGS Figure 1 is a sectional view of an embodiment of the present invention in collapsed condition.
Figure 2 is a sectional view of the embodiment of the present invention of Figure 1 in an expanded condition.
Figure 3 is a perspective view of the embodiment of the present invention of Figure 1 and 2.
Figure 4 is a perspective view of a further embodiment of the present invention.
Figure 5 is a perspective view of a further embodiment of the present invention.
Figure 6 is a view of a sectional view of a further embodiment of the present invention.
Figure 7 is a view of a portion of the embodiment of Figure 6.
DETAILED DESCRIPTION OF THE INVENTION
The present invention comprises a stent or other medical generally tube-like device for implantation in the body on a temporary, semi-permanent or permanent basis, the invention comprising an expandable mesh with an expandable polymer layer on the inside of the mesh stent, on the outside of the mesh stent, within the interstices of the mesh stent or any combination thereof.
As shown in Figure 1 , an embodiment of the present invention comprises a tubular shaped stent 10 comprising a mesh 12 and an outer layer 14. In the embodiment shown in Figure 1 , the outer layer 14 covers all or most of the outer surface of mesh 12. However, the layer 14 is shown only at the top and bottom edges of the Figure for purposes of illustration to allow viewing of mesh 12. In general, outer layer 14 is a sheath-like structure which may be attached to the mesh 12 in a variety of ways as discussed later. A retention flange 16, or other mechanism, such as exposed wires, may be provided, to assist in maintaining the positioning of the structure after placement in the body, as is known in the prior art. Figure 1 shows the stent in a collapsed position which is useful for initial insertion of the stent into the body.
Referring to Figure 2, the present invention 10 is now shown in its expanded condition. It still comprises mesh 12 and an outer layer 14, again shown only at the top and bottom edges of Figure 2 for purposes of illustration. In the condition shown in Figure 2, the stent 10 may have been inserted into a duct in the body from which outer layer 14 has absorbed water and expanded. The outer layer 14 upon expansion, no longer holds mesh 12 in the collapsed position, so that it too expands to the configuration shown in Figure 2.
Figure 3 shows expanded stent 10 in perspective view. As can be seen, the mesh 12 is substantially completely covered by outer layer 14.
Figure 4 shows an alternative embodiment of the present invention. As shown, stent 40 comprises mesh 42 and inner layer 44. Inner layer 44 is similar to layer 14 of Figures 1 -3, with the exception that it is disposed within the mesh 42. Again, the stent 40 may have retention flange 46, or similar mechanism.
Figure 5 shows a further alternative embodiment of the present invention. In Figure 5, stent 50 comprises mesh 52, outer layer 54a and inner layer 54b. A portion of outer layer 54a is cut-away for purposes of illustration for viewing of mesh 52, and inner layer 54b within mesh 52. The outer and inner layers 54a and 54b are similar to layer 44 of Figure 4, and layer 14 of Figures 1 -3.
Figure 6 shows a sectional view of stent 60. In this embodiment, stent 60 comprises a mesh 62 with polymer 64 disposed within the interstices of mesh 62. Although not shown, stent 60 may have a retention flange or other means to hold the stent in place within the body. The polymer 64 is similar to the layers 54, 44 and 14 of the previous embodiments, with the exception, instead of being sheath-like as in layers 14 and 54a, or liner-like as in layers 44 and 54b, the layer 64 is now disposed within the interstices of mesh 62. Typically, an interstitial layer is formed in conjunction with an inner layer, an outer layer, or both. Figure 7 shows a portion of the stent 60 of Figure 6.
A number of materials may be used for the expandable mesh, such as stainless steel, tantalum, gold, titanium, nitinol heat sensitive material, or any suitable plastic material that may be formed so it may be collapsed, and when released, expand radially. The expandable mesh may be self-expanding. Alternatively, the mesh may not be self- expanding, which would require external, or more typically, internal assistance, usually in the form of an expansion balloon. The mesh may be any configuration and may be made in any manner, such as is disclosed in the earlier cited patents.
The polymer layers, such as layers 14, 44, 54a, 54b and 64 of the present invention may be one of the earlier described hydrophilic polymers, which expand upon hydration. Alternatively, these layers may be made of a material which expands from a first, smaller configuration to a second, larger configuration, without requiring stretching and without exerting significant force against expansion. Further, the material does not require folding or bunching to contract from the expanded, larger configuration to the smaller configuration. One material which has this property is expanded polytetrafluoroethylene (PTFE). Typically, expanded PTFE is fabricated by pulling or expanding the PTFE after extrusion so that the PTFE is expanded in a longitudinal direction. The expanded PTFE has the above-described property of being capable of being "pushed" and "pulled" between a shorter and longer length, without requiring stretching, or exerting significant resistance against expansion when going from the shorter to the longer length, and without requiring folding or bunching of the PTFE when being pushed into the shorter length from the longer length.
In the present invention, since it is desirable for the polymer layer to expand radially after insertion into the body, the PTFE may be radially expanded after extrusion. The radially expanded PTFE may be used, for example, as the layer 14 of Figures 1 and 2. The PTFE layer 14 may be placed on the mesh 12 in the configuration shown in Figure 1 , without requiring folding or bunching of the material 14, and then expand to the configuration shown in Figure 2, without offering significant resistance, and without limiting the final expanded diameter. As an alternative to radially expanded PTFE, longitudinally expanded PTFE may be used provided it is disposed on the mesh 12 such that its direction of expansion is radial. For example, a length of longitudinally expanded PTFE may be cut and wrapped around an expandable mesh 12 with the longitudinal direction perpendicular to the length of the mesh. The expanded PTFE may be desirable in comparison to a hydrophilic polymer layer when mesh 12 is non-self-expanding, since the mesh 12 can be expanded by an expansion balloon, without any significant resistance from the polymer layer during expansion. In contrast, in using a non-self-expanding mesh in combination with a hydrophilic polymer layer, it would be necessary to wait until hydration of the hydrophilic polymer prior to expansion.
In addition to expanded PTFE described above, other polymers, such as, for example, dacron may be used in the present invention. If the polymer is not expanded as with PTFE, the structure of the material should be such that the material has the above-described ability to assume a small, compressed configuration and a larger expanded configuration, without requiring stretching to the larger configuration, and without requiring folding to the smaller configuration. The material may have this property by virtue of a weave or structure in which the fibers or filaments of the material are not aligned substantially longitudinally in the direction of expansion. In this way the material has some range of movement where the fibers or filaments of the material move in an accordion or bellows-like fashion. While, on a small scale the fibers or filaments of the material may fold in on themselves upon compression, it should be noted that no large scale folding or bunching of the material occurs, so that the compression to the small size does not significantly increase the required size of the catheter. With regard to this embodiment of the invention, the expansion ratio of the material may be described as, for example, the ratio of the expanded diameter to the compressed diameter, where the compressed diameter is the diameter at which the material is compressed to its smallest size without requiring folding or bunching on a large scale, and the expanded diameter is the diameter when the material has been expanded as far as possible without stretching. It will be appreciated that a material such as expanded PTFE, or other materials as described herein, may expand beyond this, but stretching would be required.
A preferred material to use for holding the mesh in a collapsed position, until insertion in the body where it allows the mesh to expand, is a hydrophilic polymer such as that sold under the tradename AQUAVENE®. An AQUAVENE® polymer is a co-continuous blend of a non-hydrophilic polymer (elastomer) and a hydrophilic polymer (hydrogel). In a preferred embodiment, the hydrophilic component is generally in the range of approximately 15-75%, preferably 20-65% and more preferably 25-30%, by volume in the dry (non-hydrated) state. Some amount of the non-hydrophilic component is desirable to provide some physical integrity of the polymer sufficient for the purposes of the present invention. However, a cross-linked hydrogel alone can be used. It should be noted that although, as described earlier, the mesh provides a greater crush resistance than a hydrophilic polymer of the same expansion ratio, the hydrophilic polymer provides some crush resistance, so that the present invention provides enhanced crush resistance as compared with either the mesh alone or the polymer alone.
The stent of the present invention may be formed by a number of different techniques in a number of different configurations. For example, a hydrophilic polymer layer, in the form of a sheath, may be bonded to the expandable mesh in its collapsed position so that the "dry" polymer holds the expandable mesh in a collapsed state. Alternatively, the polymer may be laminated, imbedded, coated, extruded, incorporated, or molded around the expandable mesh in its collapsed condition. Upon hydration inside the body, the polymer expands and looses its ability to restrain the expandable mesh, allowing the mesh to expand radially. In some cases, it may be necessary to allow the polymer to move relative to the expandable mesh. For example, it may be desirable to use a polymer in the form of a sheath placed external and/or internal to the expandable mesh which is not bonded to or embedded within the mesh, so that the polymer does not bind the filaments of the mesh, thereby preventing it from fully expanding. In many cases, however, the polymer may be so bonded or embedded, as the polymer in the hydrated state allows for sufficient movement of the filaments of the mesh to allow it to self expand. The polymer layer of an embodiment using expanded PTFE or similar material may be coupled to the mesh using the above techniques. However, this type of polymer by itself will not hold the mesh in the collapsed configuration.
In the present invention, the expandable polymer layer or layers are designed such that they have an approximately equal expansion ratio as the expandable mesh. In this way, the expandable polymer does not in any way resist the expansion of the expandable mesh, allowing for full expansion of the mesh. It will be appreciated that there may be a slight mismatch in expansion ratios without significantly affecting the performance of the device. Further, if desired, the expansion ratio of the hydrophilic polymer may be provided such that it assists in the expansion of the mesh. For example, the hydrophilic polymer may have a slightly greater expansion ratio, which may enable some meshes to expand to a slightly larger size than the mesh would expand without the presence of the hydrophilic polymer. As described above, the polymer layer may be placed externally, internally within the interstices of the mesh, or any combination thereof. Typically, the placement of polymers interstitially may be achieved in conjunction with an external or internal layer. One preferred embodiment is to form the polymer both internal and external to the mesh in its collapsed position, so that the stent has a smooth inner lumen and a smooth outer surface. The smooth outer surface allows for easier removal of the stent, while a smooth inner surface may be helpful in increasing the time until occlusion occurs. In embodiments using a hydrophilic polymer, the polymer may expand through the mesh to some extent, so that a single polymer layer either internal or external, may provide a smooth surface both internal and external of the mesh. Further, an advantage of embodiments using a hydrophilic polymer which forms a hydrogel is that the hydrogel is typically highly biocompatible.
The existing self-expanding meshes must be pre-loaded in a sheath delivery system, which holds the mesh in a tight configuration. The present invention may eliminate the need for a sheath in some cases, since the hydrophilic polymer of the present invention restricts the mesh in a collapsed position until after insertion and until the polymer is sufficiently hydrated. This arrangement can allow for a smaller external diameter delivery system than if a sheath is necessary, because the additional diameter of the sheath becomes unnecessary since its function is undertaken by the polymer. In some cases, if the polymer hydrates too quickly a sheath may be necessary to allow placement of the stent prior to hydration. Alternatively, if desired, a coating could be applied to the polymer layer to slow down the hydration. The coating may be similar to a material used to make time release drugs, or absorbable sutures. The coating may be designed to take any desired predetermined amount of time to dissolve, to allow for any desired amount of time in which to place and maneuver the stent in the body. For examples of the suitable materials, see, for example, Barrows, Thomas H., "Synthetic Bioabsorbable Polymers," in High Performance Biomaterials. M. Szycher, ed. 1991 , pp. 243 - 257.
As described above, the polymer layer may be a hydrophilic polymer, or may be an expandable polymer that expands without stretching, such as expanded PTFE. Additionally, the layer may be internal, and/or external, and/or interstitial. It will be appreciated that in an embodiment having more than a single layer, one or more of the layers may be a hydrophilic polymer and one or more of the layers may be a material such as expanded PTFE, if desired. Such an embodiment may be useful for delaying hydration for some period, so that the stent may be placed. For example, one or more hydrophilic layers may be disposed internal, and/or external, and/or interstitial of the mesh stent. An expanded PTFE layer, for example, may then be placed internal and/or external to any hydrophilic polymer layers to delay hydration.
The above present invention may be used in a number of different fields of medicine: products may include expandable biliary, vascular, endotracheal, esophageal, and prostatic devices. The size and design may be different for each medical application.
It will be obvious to a person of ordinary skill in the art that numerous modifications and changes can be made to the above apparatus in order to accomplish the same function without departing from the spirit and scope of the present invention.

Claims

What is claimed is:
1. A stent for insertion into the interior of a body comprising:
an expandable mesh, said expandable mesh having a first configuration having a first diameter and a second configuration having a second diameter wherein said first diameter is less than said second diameter; and,
an expandable polymer coupled with said mesh, said expandable polymer being hydrophilic, said expandable polymer expanding upon hydration.
2. The stent of claim 1 wherein said expandable mesh is self- expanding.
3. The stent of claim 2 wherein said expandable polymer holds said expandable mesh in said first configuration prior to hydration of said expandable polymer, and allows said expandable mesh to expand to said second configuration upon hydration of said expandable polymer.
4. The stent of claim 1 wherein said expandable mesh comprises a material selected from the group consisting of stainless steel, tantalum, gold, titanium, nitinol, and plastic.
5. The stent of claim 1 wherein said expandable mesh has a configuration selected from the group consisting of coiled spring, braided filament, perforated tube, slit tube, and zig-zag.
6. The stent of claim 1 wherein said expandable polymer comprises a material selected from the group consisting of: a blend of a hydrophilic polymer and a non-hydrophilic polymer, hydrolyzed polyacrylonitrile, hydrophilic polyether polyurethane, polyurethane diacrylate, polyvinyl pyrrolidone, polyvinyl alcohol, polyethylene oxide and poly (hydroxyethyl methacrylate).
7. The stent of claim 1 wherein polymer is disposed on one of the inside of said mesh, the outside of said mesh, the interstices of said mesh, and any combination thereof.
8. The stent of claim 1 said expandable polymer has an additive contained therein.
9. The stent of claim 8 wherein said additive is selected from the group consisting of antibacterial, anti-microbial, anti-calcification, anti-encrustation, growth hormones, anti-cancer-related drugs, medicaments, anti-thrombogenic agents, and anti-restenosis agents.
10. The stent of claim 1 wherein said expandable polymer has a coating thereon, said coating delaying hydration of said polymer for a predetermined time.
1 1. The stent of claim 1 wherein said expandable mesh has a first expansion ratio and said expandable polymer has a second expansion ratio, wherein said first and said second expansion ratio are approximately equal.
12. The stent of claim 1 wherein said stent has an enhanced expansion force compared with said expandable mesh alone and said expandable polymer alone.
13. The stent of claim 1 wherein said stent has an enhanced crush resistance compared with said expandable mesh alone and said expandable polymer alone.
14. The stent of claim 1 wherein said expandable polymer inhibits tissue in-growth through walls of said stent.
15. The stent of claim 1 wherein said expandable polymer inhibits liquid flow through walls of said stent.
16. A stent for insertion into the interior of a body comprising:
an expandable mesh, said expandable mesh having a first configuration having a first diameter and a second configuration having a second diameter wherein said first diameter is smaller than said second diameter; and,
an expandable polymer coupled with said mesh, said expandable polymer having a third configuration having a third diameter and a fourth configuration having a fourth diameter, said fourth diameter greater than said third diameter, wherein said expandable polymer is moveable between said third configuration and said fourth configuration without significant resistance and is moveable between said fourth configuration and said third configuration without folding or bunching.
17. The expandable mesh as described in claim 16 wherein said expandable polymer comprises expanded PTFE.
18. The stent of claim 16 wherein said expandable mesh is self- expanding.
19. The stent of claim 16 wherein said expandable mesh comprises a material selected from the group consisting of stainless steel, tantalum, gold, titanium, nitinol, and plastic.
20. The stent of claim 16 wherein said expandable mesh has a configuration selected from the group consisting of coiled spring, braided filament, perforated tube, slit tube, and zig-zag.
21. The stent of claim 16 wherein polymer is disposed on one of the inside of said mesh, the outside of said mesh, the interstices of said mesh, and any combination thereof.
22. The stent of claim 16 wherein said expandable mesh has a first expansion ratio and said polymer has a second expansion ratio, wherein said first and said second expansion ratio are approximately equal.
23. The stent of claim 16 wherein said expandable polymer inhibits tissue in-growth through walls of said stent.
24. The stent of claim 16 wherein said expandable polymer inhibits liquid flow through walls of said stent.
PCT/US1996/002406 1995-02-22 1996-02-22 Covered expanding mesh stent WO1996025897A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AU49296/96A AU719980B2 (en) 1995-02-22 1996-02-22 Covered expanding mesh stent
CA002213403A CA2213403C (en) 1995-02-22 1996-02-22 Covered expanding mesh stent
EP96905567A EP0810845A2 (en) 1995-02-22 1996-02-22 Covered expanding mesh stent

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39214395A 1995-02-22 1995-02-22
US08/392,143 1995-02-22

Publications (2)

Publication Number Publication Date
WO1996025897A2 true WO1996025897A2 (en) 1996-08-29
WO1996025897A3 WO1996025897A3 (en) 1996-11-21

Family

ID=23549417

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1996/002406 WO1996025897A2 (en) 1995-02-22 1996-02-22 Covered expanding mesh stent

Country Status (5)

Country Link
US (2) US5674241A (en)
EP (1) EP0810845A2 (en)
AU (1) AU719980B2 (en)
CA (1) CA2213403C (en)
WO (1) WO1996025897A2 (en)

Cited By (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998000090A3 (en) * 1996-07-03 1998-01-08 Baxter Int Stented, radially expandable, tubular PTFE grafts
WO1998007389A1 (en) * 1996-08-19 1998-02-26 Cook Incorporated Endovascular prosthetic device, and method of use
WO1998019636A2 (en) * 1996-11-07 1998-05-14 Vascular Science Inc. Medical grafting methods and apparatus
WO1998019629A2 (en) * 1996-11-07 1998-05-14 Vascular Science Inc. Medical grafting connectors and fasteners
WO1998029148A1 (en) * 1996-12-31 1998-07-09 Scimed Life Systems, Inc. Multilayer liquid absorption and deformation devices
EP0941714A1 (en) * 1998-03-09 1999-09-15 Biocompatibles Limited Urological stent
WO1999045852A3 (en) * 1998-03-09 1999-12-23 Corvascular Inc Anastomosis device and method
WO2000002599A1 (en) * 1998-07-08 2000-01-20 Advanced Biocompatible Coatings Inc. Biocompatible metallic stents with hydroxy methacrylate coating
US6036702A (en) * 1997-04-23 2000-03-14 Vascular Science Inc. Medical grafting connectors and fasteners
US6110188A (en) * 1998-03-09 2000-08-29 Corvascular, Inc. Anastomosis method
US6113612A (en) * 1998-11-06 2000-09-05 St. Jude Medical Cardiovascular Group, Inc. Medical anastomosis apparatus
EP0895761A3 (en) * 1997-08-04 2000-09-20 Schneider (Usa) Inc. Balloon expandable braided stent with restraint
US6152937A (en) * 1998-11-06 2000-11-28 St. Jude Medical Cardiovascular Group, Inc. Medical graft connector and methods of making and installing same
US6241741B1 (en) 1998-03-09 2001-06-05 Corvascular Surgical Systems, Inc. Anastomosis device and method
US6387095B1 (en) 1998-02-09 2002-05-14 Loren R. Kennett Surgical device comprising a radially expandable non-conductive sheath
WO2002041931A3 (en) * 2000-11-27 2002-10-10 Medtronic Inc Stents and methods for preparing stents
EP1262153A1 (en) * 2001-05-31 2002-12-04 Centrafid S.A. Stent for a vascular vessel
US6602263B1 (en) 1999-11-30 2003-08-05 St. Jude Medical Atg, Inc. Medical grafting methods and apparatus
US6660015B1 (en) 1998-01-30 2003-12-09 St. Jude Medical Atg, Inc. Medical graft connector or plug structures, and methods of making and installing same
US6712836B1 (en) 1999-05-13 2004-03-30 St. Jude Medical Atg, Inc. Apparatus and methods for closing septal defects and occluding blood flow
WO2004064894A3 (en) * 2003-01-15 2005-06-09 Scimed Life Systems Inc Intraluminally placeable textile catheter, drain and stent
US6994713B2 (en) 1998-01-30 2006-02-07 St. Jude Medical Atg, Inc. Medical graft connector or plug structures, and methods of making and installing same
US7265199B2 (en) 2000-04-11 2007-09-04 Celonova Biosciences Germany Gmbh Poly-tri-fluoro-ethoxypolyphosphazene coverings and films
EP1140244B2 (en) 1998-12-23 2008-01-09 Atrium Medical Corporation Self-expanding prosthesis with biocompatible coating
US7452372B2 (en) * 2005-09-22 2008-11-18 Boston Scientific Scimed, Inc. Bifurcated stent
US7691128B2 (en) 2002-05-06 2010-04-06 St. Jude Medical, Cardiology Division, Inc. PFO closure devices and related methods of use
US7717937B2 (en) 2001-06-01 2010-05-18 St. Jude Medical, Cardiology Division, Inc. Closure devices, related delivery methods and tools, and related methods of use
US7922764B2 (en) 2006-10-10 2011-04-12 Celonova Bioscience, Inc. Bioprosthetic heart valve with polyphosphazene
US8007821B2 (en) 2001-01-11 2011-08-30 Celonova Biosciences Germany Gmbh Substrates containing polyphosphazene as matrices and substrates containing polyphosphazene with microstructured surface
US8101275B2 (en) 2001-08-17 2012-01-24 Celonova Biosciences, Inc. Device based on nitinol, a process for its production, and its use
US8114102B2 (en) 2003-06-16 2012-02-14 St. Jude Medical Atg, Inc. Temporary hemostatic plug apparatus and method of use
US8337650B2 (en) 1995-03-10 2012-12-25 Bard Peripheral Vascular, Inc. Methods for making a supported graft
US8372112B2 (en) 2003-04-11 2013-02-12 St. Jude Medical, Cardiology Division, Inc. Closure devices, related delivery methods, and related methods of use
US8574264B2 (en) 2003-04-11 2013-11-05 St. Jude Medical, Cardiology Division, Inc. Method for retrieving a closure device
US8617337B2 (en) 1999-02-02 2013-12-31 Bard Peripheral Vascular, Inc. Partial encapsulation of stents
US8617441B2 (en) 1995-03-10 2013-12-31 Bard Peripheral Vascular, Inc. Methods for making an encapsulated stent
US9080146B2 (en) 2001-01-11 2015-07-14 Celonova Biosciences, Inc. Substrates containing polyphosphazene as matrices and substrates containing polyphosphazene with a micro-structured surface
US9107850B2 (en) 2004-10-25 2015-08-18 Celonova Biosciences, Inc. Color-coded and sized loadable polymeric particles for therapeutic and/or diagnostic applications and methods of preparing and using the same
US9114162B2 (en) 2004-10-25 2015-08-25 Celonova Biosciences, Inc. Loadable polymeric particles for enhanced imaging in clinical applications and methods of preparing and using the same
US10973770B2 (en) 2004-10-25 2021-04-13 Varian Medical Systems, Inc. Color-coded and sized loadable polymeric particles for therapeutic and/or diagnostic applications and methods of preparing and using the same

Families Citing this family (418)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6039749A (en) 1994-02-10 2000-03-21 Endovascular Systems, Inc. Method and apparatus for deploying non-circular stents and graftstent complexes
CA2213403C (en) * 1995-02-22 2007-01-16 Menlo Care, Inc. Covered expanding mesh stent
US6558798B2 (en) 1995-02-22 2003-05-06 Scimed Life Systems, Inc. Hydrophilic coating and substrates coated therewith having enhanced durability and lubricity
US6231600B1 (en) 1995-02-22 2001-05-15 Scimed Life Systems, Inc. Stents with hybrid coating for medical devices
US7204848B1 (en) 1995-03-01 2007-04-17 Boston Scientific Scimed, Inc. Longitudinally flexible expandable stent
US6124523A (en) * 1995-03-10 2000-09-26 Impra, Inc. Encapsulated stent
US6774278B1 (en) 1995-06-07 2004-08-10 Cook Incorporated Coated implantable medical device
US5769882A (en) * 1995-09-08 1998-06-23 Medtronic, Inc. Methods and apparatus for conformably sealing prostheses within body lumens
US6428571B1 (en) 1996-01-22 2002-08-06 Scimed Life Systems, Inc. Self-sealing PTFE vascular graft and manufacturing methods
US5800512A (en) * 1996-01-22 1998-09-01 Meadox Medicals, Inc. PTFE vascular graft
US5607478A (en) * 1996-03-14 1997-03-04 Meadox Medicals Inc. Yarn wrapped PTFE tubular prosthesis
US6071285A (en) * 1996-03-25 2000-06-06 Lashinski; Robert D. Rapid exchange folded balloon catheter and stent delivery system
US6060534A (en) 1996-07-11 2000-05-09 Scimed Life Systems, Inc. Medical devices comprising ionically and non-ionically crosslinked polymer hydrogels having improved mechanical properties
WO1998012990A1 (en) 1996-09-26 1998-04-02 Scimed Life Systems, Inc. Support structure/membrane composite medical device
US5824046A (en) * 1996-09-27 1998-10-20 Scimed Life Systems, Inc. Covered stent
US5755778A (en) * 1996-10-16 1998-05-26 Nitinol Medical Technologies, Inc. Anastomosis device
US6010529A (en) * 1996-12-03 2000-01-04 Atrium Medical Corporation Expandable shielded vessel support
US5925074A (en) * 1996-12-03 1999-07-20 Atrium Medical Corporation Vascular endoprosthesis and method
US6090128A (en) * 1997-02-20 2000-07-18 Endologix, Inc. Bifurcated vascular graft deployment device
CA2282748C (en) 1997-03-05 2007-11-20 Boston Scientific Limited Conformal laminate stent device
US6258120B1 (en) * 1997-12-23 2001-07-10 Embol-X, Inc. Implantable cerebral protection device and methods of use
CA2241558A1 (en) * 1997-06-24 1998-12-24 Advanced Cardiovascular Systems, Inc. Stent with reinforced struts and bimodal deployment
US6070589A (en) 1997-08-01 2000-06-06 Teramed, Inc. Methods for deploying bypass graft stents
US6306166B1 (en) 1997-08-13 2001-10-23 Scimed Life Systems, Inc. Loading and release of water-insoluble drugs
US6485514B1 (en) * 1997-12-12 2002-11-26 Supergen, Inc. Local delivery of therapeutic agents
US6530952B2 (en) 1997-12-29 2003-03-11 The Cleveland Clinic Foundation Bioprosthetic cardiovascular valve system
US6488701B1 (en) 1998-03-31 2002-12-03 Medtronic Ave, Inc. Stent-graft assembly with thin-walled graft component and method of manufacture
US6077296A (en) 1998-03-04 2000-06-20 Endologix, Inc. Endoluminal vascular prosthesis
US5925060A (en) * 1998-03-13 1999-07-20 B. Braun Celsa Covered self-expanding vascular occlusion device
DE69820023T2 (en) 1998-03-26 2004-09-02 Biomat B.V. Endovascular vascular prostheses with a polymer coating
US7208010B2 (en) 2000-10-16 2007-04-24 Conor Medsystems, Inc. Expandable medical device for delivery of beneficial agent
US6290731B1 (en) 1998-03-30 2001-09-18 Cordis Corporation Aortic graft having a precursor gasket for repairing an abdominal aortic aneurysm
US6241762B1 (en) 1998-03-30 2001-06-05 Conor Medsystems, Inc. Expandable medical device with ductile hinges
US6656215B1 (en) 2000-11-16 2003-12-02 Cordis Corporation Stent graft having an improved means for attaching a stent to a graft
EP1555036B1 (en) 1998-04-27 2010-05-05 Surmodics Inc. Bioactive agent release coating
US6099559A (en) * 1998-05-28 2000-08-08 Medtronic Ave, Inc. Endoluminal support assembly with capped ends
ATE342014T1 (en) 1998-06-19 2006-11-15 Endologix Inc SELF-EXPANDING BRANCHING ENDOVASCULAR PROSTHESIS
US6461380B1 (en) 1998-07-28 2002-10-08 Advanced Cardiovascular Systems, Inc. Stent configuration
US6143022A (en) * 1998-08-24 2000-11-07 Medtronic Ave, Inc. Stent-graft assembly with dual configuration graft component and method of manufacture
US6746489B2 (en) 1998-08-31 2004-06-08 Wilson-Cook Medical Incorporated Prosthesis having a sleeve valve
US6494879B2 (en) 1998-10-15 2002-12-17 Scimed Life Systems, Inc. Treating urinary retention
US6290692B1 (en) * 1998-11-03 2001-09-18 Daniel J. Klima Catheter support structure
US6258118B1 (en) 1998-11-25 2001-07-10 Israel Aircraft Industries Ltd. Removable support device
US6413273B1 (en) 1998-11-25 2002-07-02 Israel Aircraft Industries Ltd. Method and system for temporarily supporting a tubular organ
US6660030B2 (en) 1998-12-11 2003-12-09 Endologix, Inc. Bifurcation graft deployment catheter
JP4189127B2 (en) 1998-12-11 2008-12-03 エンドロジックス、インク Intraluminal artificial blood vessels
US6197049B1 (en) 1999-02-17 2001-03-06 Endologix, Inc. Articulating bifurcation graft
US6733523B2 (en) 1998-12-11 2004-05-11 Endologix, Inc. Implantable vascular graft
US6187036B1 (en) 1998-12-11 2001-02-13 Endologix, Inc. Endoluminal vascular prosthesis
US6120847A (en) * 1999-01-08 2000-09-19 Scimed Life Systems, Inc. Surface treatment method for stent coating
US6530950B1 (en) 1999-01-12 2003-03-11 Quanam Medical Corporation Intraluminal stent having coaxial polymer member
CA2329214A1 (en) * 1999-01-22 2000-07-27 Gore Enterprise Holdings, Inc. A biliary stent-graft
US7018401B1 (en) 1999-02-01 2006-03-28 Board Of Regents, The University Of Texas System Woven intravascular devices and methods for making the same and apparatus for delivery of the same
US6419692B1 (en) 1999-02-03 2002-07-16 Scimed Life Systems, Inc. Surface protection method for stents and balloon catheters for drug delivery
US8034100B2 (en) 1999-03-11 2011-10-11 Endologix, Inc. Graft deployment system
US6261316B1 (en) 1999-03-11 2001-07-17 Endologix, Inc. Single puncture bifurcation graft deployment system
US6620192B1 (en) * 1999-03-16 2003-09-16 Advanced Cardiovascular Systems, Inc. Multilayer stent
US6364903B2 (en) 1999-03-19 2002-04-02 Meadox Medicals, Inc. Polymer coated stent
US6136021A (en) * 1999-03-23 2000-10-24 Cardiac Pacemakers, Inc. Expandable electrode for coronary venous leads
US6156373A (en) * 1999-05-03 2000-12-05 Scimed Life Systems, Inc. Medical device coating methods and devices
US6673103B1 (en) * 1999-05-20 2004-01-06 Scimed Life Systems, Inc. Mesh and stent for increased flexibility
US6258121B1 (en) 1999-07-02 2001-07-10 Scimed Life Systems, Inc. Stent coating
US6652570B2 (en) * 1999-07-02 2003-11-25 Scimed Life Systems, Inc. Composite vascular graft
US6364904B1 (en) * 1999-07-02 2002-04-02 Scimed Life Systems, Inc. Helically formed stent/graft assembly
US7815590B2 (en) 1999-08-05 2010-10-19 Broncus Technologies, Inc. Devices for maintaining patency of surgically created channels in tissue
EP1143864B1 (en) 1999-08-05 2004-02-04 Broncus Technologies, Inc. Methods and devices for creating collateral channels in the lungs
US6712812B2 (en) 1999-08-05 2004-03-30 Broncus Technologies, Inc. Devices for creating collateral channels
US6749606B2 (en) 1999-08-05 2004-06-15 Thomas Keast Devices for creating collateral channels
US20010018609A1 (en) * 1999-08-11 2001-08-30 Scott Smith Seamless braided or spun stent cover
US6371980B1 (en) * 1999-08-30 2002-04-16 Cardiovasc, Inc. Composite expandable device with impervious polymeric covering and bioactive coating thereon, delivery apparatus and method
AU3885701A (en) * 1999-09-20 2001-04-24 Nuvasive, Inc. Annulotomy closure device
US6964674B1 (en) * 1999-09-20 2005-11-15 Nuvasive, Inc. Annulotomy closure device
US6533806B1 (en) * 1999-10-01 2003-03-18 Scimed Life Systems, Inc. Balloon yielded delivery system and endovascular graft design for easy deployment
US6334868B1 (en) 1999-10-08 2002-01-01 Advanced Cardiovascular Systems, Inc. Stent cover
US6613075B1 (en) 1999-10-27 2003-09-02 Cordis Corporation Rapid exchange self-expanding stent delivery catheter system
US6475235B1 (en) 1999-11-16 2002-11-05 Iowa-India Investments Company, Limited Encapsulated stent preform
US20010053931A1 (en) * 1999-11-24 2001-12-20 Salvatore J. Abbruzzese Thin-layered, endovascular silk-covered stent device and method of manufacture thereof
US6245100B1 (en) 2000-02-01 2001-06-12 Cordis Corporation Method for making a self-expanding stent-graft
US6296661B1 (en) 2000-02-01 2001-10-02 Luis A. Davila Self-expanding stent-graft
US7044980B2 (en) * 2000-02-03 2006-05-16 Boston Scientific Scimed, Inc. Facilitating drainage
EP1267748B1 (en) * 2000-03-09 2006-06-28 Design & Performance - Cyprus Limited Stent with cover connectors
US6613082B2 (en) 2000-03-13 2003-09-02 Jun Yang Stent having cover with drug delivery capability
US6379382B1 (en) 2000-03-13 2002-04-30 Jun Yang Stent having cover with drug delivery capability
US8088060B2 (en) 2000-03-15 2012-01-03 Orbusneich Medical, Inc. Progenitor endothelial cell capturing with a drug eluting implantable medical device
US9522217B2 (en) 2000-03-15 2016-12-20 Orbusneich Medical, Inc. Medical device with coating for capturing genetically-altered cells and methods for using same
US20030114918A1 (en) * 2000-04-28 2003-06-19 Garrison Michi E. Stent graft assembly and method
US6451050B1 (en) 2000-04-28 2002-09-17 Cardiovasc, Inc. Stent graft and method
US6520984B1 (en) 2000-04-28 2003-02-18 Cardiovasc, Inc. Stent graft assembly and method
WO2001082833A2 (en) 2000-04-28 2001-11-08 Cardiovasc, Inc. Stent graft assembly and method
US6616689B1 (en) 2000-05-03 2003-09-09 Advanced Cardiovascular Systems, Inc. Intravascular stent
JP2004506469A (en) 2000-08-18 2004-03-04 アトリテック, インコーポレイテッド Expandable implantable device for filtering blood flow from the atrial appendage
US6695833B1 (en) * 2000-09-27 2004-02-24 Nellix, Inc. Vascular stent-graft apparatus and forming method
US6652574B1 (en) 2000-09-28 2003-11-25 Vascular Concepts Holdings Limited Product and process for manufacturing a wire stent coated with a biocompatible fluoropolymer
DE60112318D1 (en) 2000-10-16 2005-09-01 Conor Medsystems Inc EXPANDABLE MEDICAL DEVICE FOR DELIVERING A REMEDY
US6833153B1 (en) * 2000-10-31 2004-12-21 Advanced Cardiovascular Systems, Inc. Hemocompatible coatings on hydrophobic porous polymers
US7807210B1 (en) 2000-10-31 2010-10-05 Advanced Cardiovascular Systems, Inc. Hemocompatible polymers on hydrophobic porous polymers
US6945991B1 (en) 2000-11-28 2005-09-20 Boston Scientific/Scimed Life Systems, Inc. Composite tubular prostheses
US6900197B2 (en) * 2000-12-15 2005-05-31 Mitokor Cobalt-porphyrin complexes and use thereof as an anti-obesity agent
US20040030377A1 (en) * 2001-10-19 2004-02-12 Alexander Dubson Medicated polymer-coated stent assembly
US20020084178A1 (en) * 2000-12-19 2002-07-04 Nicast Corporation Ltd. Method and apparatus for manufacturing polymer fiber shells via electrospinning
US7244272B2 (en) 2000-12-19 2007-07-17 Nicast Ltd. Vascular prosthesis and method for production thereof
US6929660B1 (en) 2000-12-22 2005-08-16 Advanced Cardiovascular Systems, Inc. Intravascular stent
US6641607B1 (en) 2000-12-29 2003-11-04 Advanced Cardiovascular Systems, Inc. Double tube stent
EP1377421A4 (en) * 2001-03-20 2004-05-26 Nicast Ltd Polymer fiber tubular structure having improved kinking resistance
DE10118944B4 (en) 2001-04-18 2013-01-31 Merit Medical Systems, Inc. Removable, essentially cylindrical implants
US6695804B2 (en) 2001-04-24 2004-02-24 Charles Dennis Rugenstein Device for removal of fatty debris from blood
US6685745B2 (en) 2001-05-15 2004-02-03 Scimed Life Systems, Inc. Delivering an agent to a patient's body
US6981964B2 (en) * 2001-05-22 2006-01-03 Boston Scientific Scimed, Inc. Draining bodily fluids with a stent
US6887215B2 (en) * 2001-06-01 2005-05-03 Boston Scientific Scimed, Inc. Compressible ureteral stent for comfort
KR20020094074A (en) * 2001-06-07 2002-12-18 (주)에이치비메디컬스 Implantation tube in the body
US6939373B2 (en) * 2003-08-20 2005-09-06 Advanced Cardiovascular Systems, Inc. Intravascular stent
EP1399200B2 (en) * 2001-06-11 2014-07-02 Boston Scientific Limited COMPOSITE ePTFE/TEXTILE PROSTHESIS
US6629994B2 (en) * 2001-06-11 2003-10-07 Advanced Cardiovascular Systems, Inc. Intravascular stent
US7828833B2 (en) 2001-06-11 2010-11-09 Boston Scientific Scimed, Inc. Composite ePTFE/textile prosthesis
US7560006B2 (en) * 2001-06-11 2009-07-14 Boston Scientific Scimed, Inc. Pressure lamination method for forming composite ePTFE/textile and ePTFE/stent/textile prostheses
US6635083B1 (en) 2001-06-25 2003-10-21 Advanced Cardiovascular Systems, Inc. Stent with non-linear links and method of use
US6749629B1 (en) 2001-06-27 2004-06-15 Advanced Cardiovascular Systems, Inc. Stent pattern with figure-eights
US8715312B2 (en) * 2001-07-20 2014-05-06 Microvention, Inc. Aneurysm treatment device and method of use
US7572288B2 (en) * 2001-07-20 2009-08-11 Microvention, Inc. Aneurysm treatment device and method of use
US8252040B2 (en) 2001-07-20 2012-08-28 Microvention, Inc. Aneurysm treatment device and method of use
US7547321B2 (en) 2001-07-26 2009-06-16 Alveolus Inc. Removable stent and method of using the same
US7842083B2 (en) 2001-08-20 2010-11-30 Innovational Holdings, Llc. Expandable medical device with improved spatial distribution
US6675809B2 (en) 2001-08-27 2004-01-13 Richard S. Stack Satiation devices and methods
US6845776B2 (en) 2001-08-27 2005-01-25 Richard S. Stack Satiation devices and methods
US20040117031A1 (en) * 2001-08-27 2004-06-17 Stack Richard S. Satiation devices and methods
US7097665B2 (en) 2003-01-16 2006-08-29 Synecor, Llc Positioning tools and methods for implanting medical devices
CN101810521B (en) 2001-08-27 2015-05-13 辛尼科有限责任公司 Satiation devices and methods
US7708712B2 (en) * 2001-09-04 2010-05-04 Broncus Technologies, Inc. Methods and devices for maintaining patency of surgically created channels in a body organ
US6827737B2 (en) * 2001-09-25 2004-12-07 Scimed Life Systems, Inc. EPTFE covering for endovascular prostheses and method of manufacture
US20030065386A1 (en) * 2001-09-28 2003-04-03 Weadock Kevin Shaun Radially expandable endoprosthesis device with two-stage deployment
US20030077310A1 (en) 2001-10-22 2003-04-24 Chandrashekhar Pathak Stent coatings containing HMG-CoA reductase inhibitors
DE10159708A1 (en) * 2001-12-05 2003-06-18 Bayer Ag Alkaline chloride electrolysis cell with gas diffusion electrodes
US20030153971A1 (en) * 2002-02-14 2003-08-14 Chandru Chandrasekaran Metal reinforced biodegradable intraluminal stents
US8506647B2 (en) 2002-02-14 2013-08-13 Boston Scientific Scimed, Inc. System for maintaining body canal patency
US20030153972A1 (en) * 2002-02-14 2003-08-14 Michael Helmus Biodegradable implantable or insertable medical devices with controlled change of physical properties leading to biomechanical compatibility
US7146984B2 (en) 2002-04-08 2006-12-12 Synecor, Llc Method and apparatus for modifying the exit orifice of a satiation pouch
US6656220B1 (en) 2002-06-17 2003-12-02 Advanced Cardiovascular Systems, Inc. Intravascular stent
US7097850B2 (en) 2002-06-18 2006-08-29 Surmodics, Inc. Bioactive agent release coating and controlled humidity method
US7343659B2 (en) * 2002-07-10 2008-03-18 Boston Scientific Scimed, Inc. Method of making a medical device
US7556643B2 (en) * 2002-07-24 2009-07-07 Boston Scientific Scimed, Inc. Graft inside stent
MXPA05001845A (en) 2002-08-15 2005-11-17 Gmp Cardiac Care Inc Stent-graft with rails.
AU2003257604A1 (en) * 2002-08-23 2004-03-29 Bridgestone Corporation Stent and process for producing the same
WO2004026183A2 (en) 2002-09-20 2004-04-01 Nellix, Inc. Stent-graft with positioning anchor
US7326238B1 (en) 2002-09-30 2008-02-05 Abbott Cardiovascular Systems Inc. Method and apparatus for treating vulnerable plaque
US20060265043A1 (en) * 2002-09-30 2006-11-23 Evgenia Mandrusov Method and apparatus for treating vulnerable plaque
US7008411B1 (en) * 2002-09-30 2006-03-07 Advanced Cardiovascular Systems, Inc. Method and apparatus for treating vulnerable plaque
US7794494B2 (en) 2002-10-11 2010-09-14 Boston Scientific Scimed, Inc. Implantable medical devices
EP2260882B1 (en) * 2002-10-11 2020-03-04 Boston Scientific Limited Implantable medical devices
US7976936B2 (en) * 2002-10-11 2011-07-12 University Of Connecticut Endoprostheses
GB0223870D0 (en) * 2002-10-14 2002-11-20 Cathnet Science Holding As Stent assembly
US7300459B2 (en) * 2002-10-17 2007-11-27 Heuser Richard R Stent with covering and differential dilation
US20040093056A1 (en) 2002-10-26 2004-05-13 Johnson Lianw M. Medical appliance delivery apparatus and method of use
US7959671B2 (en) 2002-11-05 2011-06-14 Merit Medical Systems, Inc. Differential covering and coating methods
US7875068B2 (en) 2002-11-05 2011-01-25 Merit Medical Systems, Inc. Removable biliary stent
US7527644B2 (en) 2002-11-05 2009-05-05 Alveolus Inc. Stent with geometry determinated functionality and method of making the same
US7637942B2 (en) 2002-11-05 2009-12-29 Merit Medical Systems, Inc. Coated stent with geometry determinated functionality and method of making the same
US20040148016A1 (en) * 2002-11-07 2004-07-29 Klein Dean A. Biocompatible medical device coatings
EP1560548A2 (en) * 2002-11-15 2005-08-10 GMP Cardiac Care, Inc. Rail stent-graft for repairing abdominal aortic aneurysm
US20040111144A1 (en) * 2002-12-06 2004-06-10 Lawin Laurie R. Barriers for polymeric coatings
US20040143342A1 (en) 2003-01-16 2004-07-22 Stack Richard S. Satiation pouches and methods of use
US7166088B2 (en) 2003-01-27 2007-01-23 Heuser Richard R Catheter introducer system
US9333102B2 (en) * 2003-02-24 2016-05-10 Allium Medical Solutions Ltd. Stent
US7318836B2 (en) 2003-03-11 2008-01-15 Boston Scientific Scimed, Inc. Covered stent
ATE526038T1 (en) 2003-03-28 2011-10-15 Innovational Holdings Llc IMPLANTABLE MEDICAL DEVICE WITH CONTINUOUS MEDIUM CONCENTRATION DISTANCE
US7637934B2 (en) 2003-03-31 2009-12-29 Merit Medical Systems, Inc. Medical appliance optical delivery and deployment apparatus and method
US20040199246A1 (en) * 2003-04-02 2004-10-07 Scimed Life Systems, Inc. Expandable stent
GB0309317D0 (en) * 2003-04-24 2003-06-04 Dental Root Filling Products L Composition
US20040215338A1 (en) * 2003-04-24 2004-10-28 Jeff Elkins Method and system for drug delivery to abdominal aortic or thoracic aortic aneurysms
US7651529B2 (en) 2003-05-09 2010-01-26 Boston Scientific Scimed, Inc. Stricture retractor
WO2004110304A2 (en) * 2003-05-29 2004-12-23 Secor Medical, Llc Filament based prosthesis
US8021418B2 (en) * 2003-06-19 2011-09-20 Boston Scientific Scimed, Inc. Sandwiched radiopaque marker on covered stent
US7131993B2 (en) * 2003-06-25 2006-11-07 Boston Scientific Scimed, Inc. Varying circumferential spanned connectors in a stent
US7318945B2 (en) * 2003-07-09 2008-01-15 Medtronic Vascular, Inc. Laminated drug-polymer coated stent having dipped layers
US8308682B2 (en) 2003-07-18 2012-11-13 Broncus Medical Inc. Devices for maintaining patency of surgically created channels in tissue
US8002740B2 (en) 2003-07-18 2011-08-23 Broncus Technologies, Inc. Devices for maintaining patency of surgically created channels in tissue
AU2003253446A1 (en) * 2003-07-29 2005-02-15 Jin-Hong Kim Self-expandable stent
US7318944B2 (en) * 2003-08-07 2008-01-15 Medtronic Vascular, Inc. Extrusion process for coating stents
US7794476B2 (en) * 2003-08-08 2010-09-14 Warsaw Orthopedic, Inc. Implants formed of shape memory polymeric material for spinal fixation
US7402141B2 (en) 2003-08-27 2008-07-22 Heuser Richard R Catheter guidewire system using concentric wires
US20050060020A1 (en) * 2003-09-17 2005-03-17 Scimed Life Systems, Inc. Covered stent with biologically active material
US7296998B2 (en) * 2003-09-22 2007-11-20 Bartee Chaddick M Hydrophilic high density PTFE medical barrier
US20050247320A1 (en) 2003-10-10 2005-11-10 Stack Richard S Devices and methods for retaining a gastro-esophageal implant
US8206456B2 (en) 2003-10-10 2012-06-26 Barosense, Inc. Restrictive and/or obstructive implant system for inducing weight loss
US20090118817A1 (en) * 2005-06-16 2009-05-07 Mayo Foundation For Medical Education And Research Magnetic Medical Apparatus, Kits, and Methods
US8465453B2 (en) * 2003-12-03 2013-06-18 Mayo Foundation For Medical Education And Research Kits, apparatus and methods for magnetically coating medical devices with living cells
US8182528B2 (en) 2003-12-23 2012-05-22 Sadra Medical, Inc. Locking heart valve anchor
US8052749B2 (en) 2003-12-23 2011-11-08 Sadra Medical, Inc. Methods and apparatus for endovascular heart valve replacement comprising tissue grasping elements
US8840663B2 (en) 2003-12-23 2014-09-23 Sadra Medical, Inc. Repositionable heart valve method
US8343213B2 (en) 2003-12-23 2013-01-01 Sadra Medical, Inc. Leaflet engagement elements and methods for use thereof
US20050137694A1 (en) 2003-12-23 2005-06-23 Haug Ulrich R. Methods and apparatus for endovascularly replacing a patient's heart valve
US7748389B2 (en) 2003-12-23 2010-07-06 Sadra Medical, Inc. Leaflet engagement elements and methods for use thereof
US20050137687A1 (en) 2003-12-23 2005-06-23 Sadra Medical Heart valve anchor and method
US7445631B2 (en) 2003-12-23 2008-11-04 Sadra Medical, Inc. Methods and apparatus for endovascularly replacing a patient's heart valve
US7381219B2 (en) 2003-12-23 2008-06-03 Sadra Medical, Inc. Low profile heart valve and delivery system
US20120041550A1 (en) 2003-12-23 2012-02-16 Sadra Medical, Inc. Methods and Apparatus for Endovascular Heart Valve Replacement Comprising Tissue Grasping Elements
US7824443B2 (en) 2003-12-23 2010-11-02 Sadra Medical, Inc. Medical implant delivery and deployment tool
US11278398B2 (en) 2003-12-23 2022-03-22 Boston Scientific Scimed, Inc. Methods and apparatus for endovascular heart valve replacement comprising tissue grasping elements
US8579962B2 (en) 2003-12-23 2013-11-12 Sadra Medical, Inc. Methods and apparatus for performing valvuloplasty
US8287584B2 (en) 2005-11-14 2012-10-16 Sadra Medical, Inc. Medical implant deployment tool
EP1702247B8 (en) 2003-12-23 2015-09-09 Boston Scientific Scimed, Inc. Repositionable heart valve
US7824442B2 (en) 2003-12-23 2010-11-02 Sadra Medical, Inc. Methods and apparatus for endovascularly replacing a heart valve
US7329279B2 (en) 2003-12-23 2008-02-12 Sadra Medical, Inc. Methods and apparatus for endovascularly replacing a patient's heart valve
US9526609B2 (en) 2003-12-23 2016-12-27 Boston Scientific Scimed, Inc. Methods and apparatus for endovascularly replacing a patient's heart valve
US7959666B2 (en) 2003-12-23 2011-06-14 Sadra Medical, Inc. Methods and apparatus for endovascularly replacing a heart valve
US8603160B2 (en) 2003-12-23 2013-12-10 Sadra Medical, Inc. Method of using a retrievable heart valve anchor with a sheath
US7780725B2 (en) 2004-06-16 2010-08-24 Sadra Medical, Inc. Everting heart valve
US9005273B2 (en) 2003-12-23 2015-04-14 Sadra Medical, Inc. Assessing the location and performance of replacement heart valves
US7530994B2 (en) * 2003-12-30 2009-05-12 Scimed Life Systems, Inc. Non-porous graft with fastening elements
US20050147734A1 (en) * 2004-01-07 2005-07-07 Jan Seppala Method and system for coating tubular medical devices
US7316709B2 (en) * 2004-01-13 2008-01-08 Advanced Cardiovascular Systems, Inc. Balloon catheter having a textured member for enhancing balloon or stent retention
WO2005077013A2 (en) 2004-02-06 2005-08-25 Georgia Tech Research Corporation Surface directed cellular attachment
CA2558661C (en) 2004-02-06 2012-09-04 Georgia Tech Research Corporation Load bearing biocompatible device
CN1964748A (en) 2004-04-06 2007-05-16 苏莫迪克斯公司 Coating compositions for bioactive agents
WO2005105003A1 (en) 2004-04-26 2005-11-10 Synecor, Llc Restrictive and/or obstructive implant for inducing weight loss
US8409167B2 (en) 2004-07-19 2013-04-02 Broncus Medical Inc Devices for delivering substances through an extra-anatomic opening created in an airway
US8048145B2 (en) 2004-07-22 2011-11-01 Endologix, Inc. Graft systems having filling structures supported by scaffolds and methods for their use
US20060036308A1 (en) * 2004-08-12 2006-02-16 Medtronic Vascular, Inc. Stent with extruded covering
US8545418B2 (en) * 2004-08-25 2013-10-01 Richard R. Heuser Systems and methods for ablation of occlusions within blood vessels
US7887579B2 (en) 2004-09-29 2011-02-15 Merit Medical Systems, Inc. Active stent
US8043361B2 (en) * 2004-12-10 2011-10-25 Boston Scientific Scimed, Inc. Implantable medical devices, and methods of delivering the same
US7758640B2 (en) * 2004-12-16 2010-07-20 Valvexchange Inc. Cardiovascular valve assembly
US9545300B2 (en) 2004-12-22 2017-01-17 W. L. Gore & Associates, Inc. Filament-wound implantable devices
DE102005003632A1 (en) 2005-01-20 2006-08-17 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Catheter for the transvascular implantation of heart valve prostheses
US8083805B2 (en) * 2005-08-16 2011-12-27 Poly-Med, Inc. Absorbable endo-urological devices and applications therefor
EP1871306A4 (en) 2005-04-01 2012-03-21 Univ Colorado A graft fixation device and method
US7962208B2 (en) 2005-04-25 2011-06-14 Cardiac Pacemakers, Inc. Method and apparatus for pacing during revascularization
US20070055365A1 (en) * 2005-04-28 2007-03-08 The Cleveland Clinic Foundation Stent with integrated filter
US20060253197A1 (en) * 2005-05-09 2006-11-09 Napier Bradford Shape-memory port-access tube
US7731654B2 (en) 2005-05-13 2010-06-08 Merit Medical Systems, Inc. Delivery device with viewing window and associated method
US20060287668A1 (en) * 2005-06-16 2006-12-21 Fawzi Natalie V Apparatus and methods for intravascular embolic protection
US9162037B2 (en) 2005-07-06 2015-10-20 Vascular Pathways, Inc. Intravenous catheter insertion device and method of use
JP2009500121A (en) 2005-07-07 2009-01-08 ネリックス・インコーポレーテッド System and method for treatment of an intraluminal aneurysm
US9101949B2 (en) 2005-08-04 2015-08-11 Eilaz Babaev Ultrasonic atomization and/or seperation system
US7896539B2 (en) 2005-08-16 2011-03-01 Bacoustics, Llc Ultrasound apparatus and methods for mixing liquids and coating stents
US8187318B2 (en) * 2005-08-31 2012-05-29 Advanced Bio Prosthetic Surfaces, Ltd. Covered stent with proximal and distal attachment, delivery catheter, and method of making same
US7712606B2 (en) 2005-09-13 2010-05-11 Sadra Medical, Inc. Two-part package for medical implant
US20070088436A1 (en) * 2005-09-29 2007-04-19 Matthew Parsons Methods and devices for stenting or tamping a fractured vertebral body
US9055942B2 (en) 2005-10-03 2015-06-16 Boston Scienctific Scimed, Inc. Endoscopic plication devices and methods
US20070213813A1 (en) 2005-12-22 2007-09-13 Symetis Sa Stent-valves for valve replacement and associated methods and systems for surgery
US9375215B2 (en) * 2006-01-20 2016-06-28 W. L. Gore & Associates, Inc. Device for rapid repair of body conduits
US8062321B2 (en) 2006-01-25 2011-11-22 Pq Bypass, Inc. Catheter system for connecting adjacent blood vessels
US7374567B2 (en) 2006-01-25 2008-05-20 Heuser Richard R Catheter system for connecting adjacent blood vessels
WO2007097983A2 (en) 2006-02-14 2007-08-30 Sadra Medical, Inc. Systems and methods for delivering a medical implant
EP1852088A1 (en) * 2006-05-05 2007-11-07 Mnemoscience GmbH Shape memory devices
US20080004696A1 (en) * 2006-06-29 2008-01-03 Valvexchange Inc. Cardiovascular valve assembly with resizable docking station
US8613698B2 (en) 2006-07-10 2013-12-24 Mcneil-Ppc, Inc. Resilient device
US10219884B2 (en) 2006-07-10 2019-03-05 First Quality Hygienic, Inc. Resilient device
US7717892B2 (en) 2006-07-10 2010-05-18 Mcneil-Ppc, Inc. Method of treating urinary incontinence
US10004584B2 (en) 2006-07-10 2018-06-26 First Quality Hygienic, Inc. Resilient intravaginal device
WO2008008794A2 (en) 2006-07-10 2008-01-17 Mc Neil-Ppc, Inc. Resilient device
EP2572673B1 (en) 2006-09-02 2015-08-19 Boston Scientific Scimed, Inc. Intestinal sleeves and associated deployment systems and methods
US7988720B2 (en) 2006-09-12 2011-08-02 Boston Scientific Scimed, Inc. Longitudinally flexible expandable stent
US9314361B2 (en) 2006-09-15 2016-04-19 Boston Scientific Scimed, Inc. System and method for anchoring stomach implant
US8778009B2 (en) * 2006-10-06 2014-07-15 Abbott Cardiovascular Systems Inc. Intravascular stent
EP3034046B1 (en) 2006-10-22 2018-01-17 IDEV Technologies, INC. Methods for securing strand ends and the resulting devices
US9622888B2 (en) 2006-11-16 2017-04-18 W. L. Gore & Associates, Inc. Stent having flexibly connected adjacent stent elements
US10188534B2 (en) * 2006-11-17 2019-01-29 Covidien Lp Stent having reduced passage of emboli and stent delivery system
US20100192959A1 (en) * 2006-12-19 2010-08-05 The Regents Of The University Of Colorado, A Body Corporate Shape memory polymer-based transcervical device for permanent or temporary sterilization
US8523931B2 (en) 2007-01-12 2013-09-03 Endologix, Inc. Dual concentric guidewire and methods of bifurcated graft deployment
KR20120106880A (en) 2007-01-21 2012-09-26 헤모텍 아게 Medical product for treating stenosis of body passages and for preventing threatening restenosis
US8221505B2 (en) 2007-02-22 2012-07-17 Cook Medical Technologies Llc Prosthesis having a sleeve valve
US20080234813A1 (en) * 2007-03-20 2008-09-25 Heuser Richard R Percutaneous Interventional Cardiology System for Treating Valvular Disease
US7896915B2 (en) 2007-04-13 2011-03-01 Jenavalve Technology, Inc. Medical device for treating a heart valve insufficiency
JP5139518B2 (en) 2007-05-07 2013-02-06 バスキュラー・パスウェイズ・インコーポレイテッド Venous catheter insertion device
JP5734650B2 (en) 2007-06-25 2015-06-17 マイクロベンション インコーポレイテッド Self-expanding prosthesis
US9192697B2 (en) 2007-07-03 2015-11-24 Hemoteq Ag Balloon catheter for treating stenosis of body passages and for preventing threatening restenosis
US7780095B2 (en) 2007-07-13 2010-08-24 Bacoustics, Llc Ultrasound pumping apparatus
US7753285B2 (en) 2007-07-13 2010-07-13 Bacoustics, Llc Echoing ultrasound atomization and/or mixing system
US20090030284A1 (en) 2007-07-18 2009-01-29 David Cole Overtube introducer for use in endoscopic bariatric surgery
CA2696993C (en) 2007-07-18 2017-01-03 Samuel T. Crews Endoscopic implant system and method
US20090054965A1 (en) * 2007-08-21 2009-02-26 Boston Scientific Scimed, Inc. Methods For Producing Embolic Devices
WO2009049677A1 (en) * 2007-10-17 2009-04-23 Syntach Ag Shape-changing medical device, kit, method of production and method of use
US20090171383A1 (en) 2007-12-31 2009-07-02 David Cole Gastric space occupier systems and methods of use
US8926688B2 (en) 2008-01-11 2015-01-06 W. L. Gore & Assoc. Inc. Stent having adjacent elements connected by flexible webs
WO2009105699A1 (en) 2008-02-22 2009-08-27 Endologix, Inc. Design and method of placement of a graft or graft system
BR112012021347A2 (en) 2008-02-26 2019-09-24 Jenavalve Tecnology Inc stent for positioning and anchoring a valve prosthesis at an implantation site in a patient's heart
US9044318B2 (en) 2008-02-26 2015-06-02 Jenavalve Technology Gmbh Stent for the positioning and anchoring of a valvular prosthesis
US8196279B2 (en) 2008-02-27 2012-06-12 C. R. Bard, Inc. Stent-graft covering process
US8020741B2 (en) 2008-03-18 2011-09-20 Barosense, Inc. Endoscopic stapling devices and methods
EP2106820A1 (en) * 2008-03-31 2009-10-07 Torsten Heilmann Expansible biocompatible coats comprising a biologically active substance
US8236040B2 (en) 2008-04-11 2012-08-07 Endologix, Inc. Bifurcated graft deployment systems and methods
AU2009240419A1 (en) 2008-04-25 2009-10-29 Nellix, Inc. Stent graft delivery system
WO2009146492A1 (en) * 2008-06-03 2009-12-10 Cochlear Limited Expandable structures
JP2011522615A (en) 2008-06-04 2011-08-04 ネリックス・インコーポレーテッド Sealing device and method of use
EP2520320B1 (en) 2008-07-01 2016-11-02 Endologix, Inc. Catheter system
EP2331015A1 (en) 2008-09-12 2011-06-15 ValveXchange Inc. Valve assembly with exchangeable valve member and a tool set for exchanging the valve member
ES2409693T3 (en) 2008-10-10 2013-06-27 Sadra Medical, Inc. Medical devices and supply systems to supply medical devices
US9119714B2 (en) * 2008-10-29 2015-09-01 The Regents Of The University Of Colorado, A Body Corporate Shape memory polymer prosthetic medical device
US7934631B2 (en) 2008-11-10 2011-05-03 Barosense, Inc. Multi-fire stapling systems and methods for delivering arrays of staples
EP2429452B1 (en) 2009-04-28 2020-01-15 Endologix, Inc. Endoluminal prosthesis system
US10772717B2 (en) 2009-05-01 2020-09-15 Endologix, Inc. Percutaneous method and device to treat dissections
US9579103B2 (en) 2009-05-01 2017-02-28 Endologix, Inc. Percutaneous method and device to treat dissections
US8961539B2 (en) 2009-05-04 2015-02-24 Boston Scientific Scimed, Inc. Endoscopic implant system and method
US9327058B2 (en) 2009-07-07 2016-05-03 Cook Medical Technologies Llc Hydrogel enhanced medical devices
WO2011005421A2 (en) 2009-07-10 2011-01-13 Boston Scientific Scimed, Inc. Use of nanocrystals for a drug delivery balloon
WO2011008989A2 (en) 2009-07-15 2011-01-20 Endologix, Inc. Stent graft
EP2453938B1 (en) 2009-07-17 2015-08-19 Boston Scientific Scimed, Inc. Nucleation of drug delivery balloons to provide improved crystal size and density
US8118856B2 (en) 2009-07-27 2012-02-21 Endologix, Inc. Stent graft
US20110144689A1 (en) * 2009-12-15 2011-06-16 Med Institute, Inc. Occlusion Device
US20110276078A1 (en) 2009-12-30 2011-11-10 Nellix, Inc. Filling structure for a graft system and methods of use
US9950139B2 (en) 2010-05-14 2018-04-24 C. R. Bard, Inc. Catheter placement device including guidewire and catheter control elements
US11925779B2 (en) 2010-05-14 2024-03-12 C. R. Bard, Inc. Catheter insertion device including top-mounted advancement components
US10384039B2 (en) 2010-05-14 2019-08-20 C. R. Bard, Inc. Catheter insertion device including top-mounted advancement components
US8932258B2 (en) 2010-05-14 2015-01-13 C. R. Bard, Inc. Catheter placement device and method
US9872971B2 (en) 2010-05-14 2018-01-23 C. R. Bard, Inc. Guidewire extension system for a catheter placement device
CA2799459A1 (en) 2010-05-25 2011-12-01 Jenavalve Technology Inc. Prosthetic heart valve and transcatheter delivered endoprosthesis comprising a prosthetic heart valve and a stent
US10420665B2 (en) 2010-06-13 2019-09-24 W. L. Gore & Associates, Inc. Intragastric device for treating obesity
US9526648B2 (en) 2010-06-13 2016-12-27 Synerz Medical, Inc. Intragastric device for treating obesity
US8628554B2 (en) 2010-06-13 2014-01-14 Virender K. Sharma Intragastric device for treating obesity
US10010439B2 (en) 2010-06-13 2018-07-03 Synerz Medical, Inc. Intragastric device for treating obesity
WO2012019145A1 (en) 2010-08-06 2012-02-09 Endoshape, Inc. Radiopaque shape memory polymers for medical devices
EP2611369A2 (en) 2010-08-30 2013-07-10 Sinusys Corporation Devices for dilating a paranasal sinus opening and for treating sinusitis
WO2012031236A1 (en) 2010-09-02 2012-03-08 Boston Scientific Scimed, Inc. Coating process for drug delivery balloons using heat-induced rewrap memory
EP4119107A3 (en) 2010-09-10 2023-02-15 Boston Scientific Limited Valve replacement devices, delivery device for a valve replacement device and method of production of a valve replacement device
WO2012051096A1 (en) 2010-10-11 2012-04-19 Dardi Peter S Hydrogel jacketed stents
EP2635241B1 (en) 2010-11-02 2019-02-20 Endologix, Inc. Apparatus for placement of a graft or graft system
WO2012068298A1 (en) 2010-11-17 2012-05-24 Endologix, Inc. Devices and methods to treat vascular dissections
WO2012097287A1 (en) * 2011-01-13 2012-07-19 Innovia Llc Endoluminal drug applicator and method of treating diseased vessels of the body
US8801768B2 (en) 2011-01-21 2014-08-12 Endologix, Inc. Graft systems having semi-permeable filling structures and methods for their use
US8690833B2 (en) 2011-01-31 2014-04-08 Vascular Pathways, Inc. Intravenous catheter and insertion device with reduced blood spatter
EP2678065B1 (en) 2011-02-25 2019-09-11 C.R. Bard Inc. Medical component insertion device including a retractable needle
CN105232195B (en) 2011-03-01 2018-06-08 恩朵罗杰克斯股份有限公司 Delivery catheter system
US9427493B2 (en) 2011-03-07 2016-08-30 The Regents Of The University Of Colorado Shape memory polymer intraocular lenses
WO2012127309A1 (en) 2011-03-21 2012-09-27 Ontorfano Matteo Disk-based valve apparatus and method for the treatment of valve dysfunction
EP2693980B1 (en) 2011-04-06 2022-07-13 Endologix LLC System for endovascular aneurysm treatment
EP2520251A1 (en) 2011-05-05 2012-11-07 Symetis SA Method and Apparatus for Compressing Stent-Valves
JP2014522263A (en) 2011-05-11 2014-09-04 マイクロベンション インコーポレイテッド Device for occluding a lumen
US8709034B2 (en) 2011-05-13 2014-04-29 Broncus Medical Inc. Methods and devices for diagnosing, monitoring, or treating medical conditions through an opening through an airway wall
US9345532B2 (en) 2011-05-13 2016-05-24 Broncus Medical Inc. Methods and devices for ablation of tissue
USD903101S1 (en) 2011-05-13 2020-11-24 C. R. Bard, Inc. Catheter
CA3048437C (en) 2011-05-26 2022-06-21 Cartiva, Inc. Tapered joint implant and related tools
CA2835893C (en) 2011-07-12 2019-03-19 Boston Scientific Scimed, Inc. Coupling system for medical devices
US8669360B2 (en) 2011-08-05 2014-03-11 Boston Scientific Scimed, Inc. Methods of converting amorphous drug substance into crystalline form
WO2013028208A1 (en) 2011-08-25 2013-02-28 Boston Scientific Scimed, Inc. Medical device with crystalline drug coating
US9131926B2 (en) 2011-11-10 2015-09-15 Boston Scientific Scimed, Inc. Direct connect flush system
US8940014B2 (en) 2011-11-15 2015-01-27 Boston Scientific Scimed, Inc. Bond between components of a medical device
WO2013078235A1 (en) 2011-11-23 2013-05-30 Broncus Medical Inc Methods and devices for diagnosing, monitoring, or treating medical conditions through an opening through an airway wall
US8951243B2 (en) 2011-12-03 2015-02-10 Boston Scientific Scimed, Inc. Medical device handle
US9510945B2 (en) 2011-12-20 2016-12-06 Boston Scientific Scimed Inc. Medical device handle
US9277993B2 (en) 2011-12-20 2016-03-08 Boston Scientific Scimed, Inc. Medical device delivery systems
WO2013112547A1 (en) 2012-01-25 2013-08-01 Boston Scientific Scimed, Inc. Valve assembly with a bioabsorbable gasket and a replaceable valve implant
JP2015509786A (en) 2012-02-29 2015-04-02 サイナシス コーポレーション Devices and methods for expanding sinus openings to treat sinusitis
US9883941B2 (en) 2012-06-19 2018-02-06 Boston Scientific Scimed, Inc. Replacement heart valve
US20140114340A1 (en) * 2012-10-19 2014-04-24 Boston Scientific Scimed, Inc. Anti-thrombus feature for implanted medical devices
US9522254B2 (en) 2013-01-30 2016-12-20 Vascular Pathways, Inc. Systems and methods for venipuncture and catheter placement
WO2014124225A1 (en) 2013-02-08 2014-08-14 Endoshape, Inc. Radiopaque polymers for medical devices
JP6533776B2 (en) 2013-03-14 2019-06-19 エンドーロジックス インコーポレイテッド System for treating an aneurysm in a patient's body and method of operating the same
US9522072B2 (en) 2013-03-15 2016-12-20 W. L. Gore & Associates, Inc. Porous materials having a fibrillar microstructure and a fracturable coating
US9545301B2 (en) 2013-03-15 2017-01-17 Covidien Lp Coated medical devices and methods of making and using same
JP6543831B2 (en) 2013-03-15 2019-07-17 エンドゥーシェイプ インコーポレイテッド Polymer composition having enhanced radiopacity
US9320592B2 (en) 2013-03-15 2016-04-26 Covidien Lp Coated medical devices and methods of making and using same
US10905539B2 (en) 2013-03-15 2021-02-02 W. L. Gore & Associates, Inc. Self-expanding, balloon expandable stent-grafts
US9687263B2 (en) 2013-05-30 2017-06-27 SinuSys Corporation Devices and methods for inserting a sinus dilator
US8870948B1 (en) 2013-07-17 2014-10-28 Cephea Valve Technologies, Inc. System and method for cardiac valve repair and replacement
US9867694B2 (en) 2013-08-30 2018-01-16 Jenavalve Technology Inc. Radially collapsible frame for a prosthetic valve and method for manufacturing such a frame
US9668890B2 (en) 2013-11-22 2017-06-06 Covidien Lp Anti-thrombogenic medical devices and methods
US10232146B2 (en) 2014-09-05 2019-03-19 C. R. Bard, Inc. Catheter insertion device including retractable needle
US9901445B2 (en) 2014-11-21 2018-02-27 Boston Scientific Scimed, Inc. Valve locking mechanism
US10299948B2 (en) 2014-11-26 2019-05-28 W. L. Gore & Associates, Inc. Balloon expandable endoprosthesis
WO2016093877A1 (en) 2014-12-09 2016-06-16 Cephea Valve Technologies, Inc. Replacement cardiac valves and methods of use and manufacture
US9789228B2 (en) 2014-12-11 2017-10-17 Covidien Lp Antimicrobial coatings for medical devices and processes for preparing such coatings
US10449043B2 (en) 2015-01-16 2019-10-22 Boston Scientific Scimed, Inc. Displacement based lock and release mechanism
US9861477B2 (en) 2015-01-26 2018-01-09 Boston Scientific Scimed Inc. Prosthetic heart valve square leaflet-leaflet stitch
US10201417B2 (en) 2015-02-03 2019-02-12 Boston Scientific Scimed Inc. Prosthetic heart valve having tubular seal
US9788942B2 (en) 2015-02-03 2017-10-17 Boston Scientific Scimed Inc. Prosthetic heart valve having tubular seal
US10285809B2 (en) 2015-03-06 2019-05-14 Boston Scientific Scimed Inc. TAVI anchoring assist device
US10426617B2 (en) 2015-03-06 2019-10-01 Boston Scientific Scimed, Inc. Low profile valve locking mechanism and commissure assembly
US10080652B2 (en) 2015-03-13 2018-09-25 Boston Scientific Scimed, Inc. Prosthetic heart valve having an improved tubular seal
EP3636226A1 (en) 2015-03-31 2020-04-15 Cartiva, Inc. Carpometacarpal (cmc) implants
WO2016161025A1 (en) 2015-03-31 2016-10-06 Cartiva, Inc. Hydrogel implants with porous materials and methods
WO2016168363A1 (en) 2015-04-14 2016-10-20 Cartiva, Inc. Tooling for creating tapered opening in tissue and related methods
EP3288495B1 (en) 2015-05-01 2019-09-25 JenaValve Technology, Inc. Device with reduced pacemaker rate in heart valve replacement
USD903100S1 (en) 2015-05-01 2020-11-24 C. R. Bard, Inc. Catheter placement device
EP4335415A2 (en) 2015-05-14 2024-03-13 Cephea Valve Technologies, Inc. Replacement mitral valves
WO2016183523A1 (en) 2015-05-14 2016-11-17 Cephea Valve Technologies, Inc. Cardiac valve delivery devices and systems
CN107708769B (en) 2015-05-15 2021-07-27 C·R·巴德股份有限公司 Catheter placement device including extendable needle safety feature
US11129737B2 (en) 2015-06-30 2021-09-28 Endologix Llc Locking assembly for coupling guidewire to delivery system
WO2017004377A1 (en) 2015-07-02 2017-01-05 Boston Scientific Scimed, Inc. Adjustable nosecone
US10195392B2 (en) 2015-07-02 2019-02-05 Boston Scientific Scimed, Inc. Clip-on catheter
US10179041B2 (en) 2015-08-12 2019-01-15 Boston Scientific Scimed Icn. Pinless release mechanism
US10136991B2 (en) 2015-08-12 2018-11-27 Boston Scientific Scimed Inc. Replacement heart valve implant
US10779940B2 (en) 2015-09-03 2020-09-22 Boston Scientific Scimed, Inc. Medical device handle
US10342660B2 (en) 2016-02-02 2019-07-09 Boston Scientific Inc. Tensioned sheathing aids
US10779980B2 (en) 2016-04-27 2020-09-22 Synerz Medical, Inc. Intragastric device for treating obesity
EP4183371A1 (en) 2016-05-13 2023-05-24 JenaValve Technology, Inc. Heart valve prosthesis delivery system and method for delivery of heart valve prosthesis with introducer sheath and loading system
US10245136B2 (en) 2016-05-13 2019-04-02 Boston Scientific Scimed Inc. Containment vessel with implant sheathing guide
US10583005B2 (en) 2016-05-13 2020-03-10 Boston Scientific Scimed, Inc. Medical device handle
US10201416B2 (en) 2016-05-16 2019-02-12 Boston Scientific Scimed, Inc. Replacement heart valve implant with invertible leaflets
US10568752B2 (en) 2016-05-25 2020-02-25 W. L. Gore & Associates, Inc. Controlled endoprosthesis balloon expansion
US11331187B2 (en) 2016-06-17 2022-05-17 Cephea Valve Technologies, Inc. Cardiac valve delivery devices and systems
US11026782B2 (en) 2016-08-11 2021-06-08 4C Medical Technologies, Inc. Heart chamber prosthetic valve implant with elevated valve section and single chamber anchoring for preservation, supplementation and/or replacement of native valve function
CN112206397B (en) 2016-09-12 2023-03-21 C·R·巴德股份有限公司 Blood control of catheter insertion device
AU2017371223B2 (en) 2016-12-09 2023-04-27 Zenflow, Inc. Systems, devices, and methods for the accurate deployment of an implant in the prostatic urethra
EP4209196A1 (en) 2017-01-23 2023-07-12 Cephea Valve Technologies, Inc. Replacement mitral valves
CA3051272C (en) 2017-01-23 2023-08-22 Cephea Valve Technologies, Inc. Replacement mitral valves
WO2018138658A1 (en) 2017-01-27 2018-08-02 Jenavalve Technology, Inc. Heart valve mimicry
CN106691645A (en) * 2017-02-05 2017-05-24 常州乐奥医疗科技股份有限公司 Vascular drug stent
EP3585471A4 (en) 2017-03-01 2021-03-10 C.R. Bard, Inc. Catheter insertion device
WO2018226915A1 (en) 2017-06-08 2018-12-13 Boston Scientific Scimed, Inc. Heart valve implant commissure support structure
US10238513B2 (en) 2017-07-19 2019-03-26 Abbott Cardiovascular Systems Inc. Intravascular stent
EP3661458A1 (en) 2017-08-01 2020-06-10 Boston Scientific Scimed, Inc. Medical implant locking mechanism
CN111225633B (en) 2017-08-16 2022-05-31 波士顿科学国际有限公司 Replacement heart valve coaptation assembly
EP3740160A2 (en) 2018-01-19 2020-11-25 Boston Scientific Scimed Inc. Inductance mode deployment sensors for transcatheter valve system
JP7047106B2 (en) 2018-01-19 2022-04-04 ボストン サイエンティフィック サイムド,インコーポレイテッド Medical device delivery system with feedback loop
US11147668B2 (en) 2018-02-07 2021-10-19 Boston Scientific Scimed, Inc. Medical device delivery system with alignment feature
WO2019165394A1 (en) 2018-02-26 2019-08-29 Boston Scientific Scimed, Inc. Embedded radiopaque marker in adaptive seal
BR112020017215A2 (en) 2018-03-07 2020-12-22 Bard Access Systems, Inc. GUIDELINE ADVANCE SYSTEMS AND REVERSE BLOOD SQUEEZE FOR A MEDICAL DEVICE INSERT SYSTEM
JP2021520873A (en) * 2018-04-09 2021-08-26 エドワーズ ライフサイエンシーズ コーポレイションEdwards Lifesciences Corporation Expandable sheath
WO2019222367A1 (en) 2018-05-15 2019-11-21 Boston Scientific Scimed, Inc. Replacement heart valve commissure assembly
US11241310B2 (en) 2018-06-13 2022-02-08 Boston Scientific Scimed, Inc. Replacement heart valve delivery device
USD921884S1 (en) 2018-07-27 2021-06-08 Bard Access Systems, Inc. Catheter insertion device
CN112469371A (en) 2018-07-29 2021-03-09 Bvw控股公司 Biliary tract stent
US11857441B2 (en) 2018-09-04 2024-01-02 4C Medical Technologies, Inc. Stent loading device
WO2020123486A1 (en) 2018-12-10 2020-06-18 Boston Scientific Scimed, Inc. Medical device delivery system including a resistance member
US11439504B2 (en) 2019-05-10 2022-09-13 Boston Scientific Scimed, Inc. Replacement heart valve with improved cusp washout and reduced loading
CN112386778A (en) 2019-08-19 2021-02-23 贝克顿·迪金森公司 Midline catheter placement device
JP2023502997A (en) 2019-11-19 2023-01-26 ゼンフロー, インコーポレイテッド Systems, devices and methods for accurate deployment and imaging of implants within the prostatic urethra
US11633193B2 (en) * 2020-09-03 2023-04-25 Covidien Lp Expandable devices and associated systems and methods

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4883699A (en) * 1984-09-21 1989-11-28 Menlo Care, Inc. Polymeric article having high tensile energy to break when hydrated
WO1990005554A2 (en) * 1988-11-07 1990-05-31 Boston Scientific Corporation Stent delivery system
US5089006A (en) * 1989-11-29 1992-02-18 Stiles Frank B Biological duct liner and installation catheter
US5139480A (en) * 1990-08-22 1992-08-18 Biotech Laboratories, Inc. Necking stents
WO1993006781A1 (en) * 1991-10-09 1993-04-15 Boston Scientific Corporation Impregnated stent
WO1994024961A1 (en) * 1993-04-23 1994-11-10 Schneider (Usa) Inc. Covered stent and stent delivery device
WO1995011055A1 (en) * 1993-10-22 1995-04-27 Scimed Lifesystems, Inc. Improved stent delivery apparatus and method

Family Cites Families (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US31855A (en) * 1861-03-26 G Weiland Straw-carrier for threshing-machines
US29343A (en) * 1860-07-24 Improved punching-machine
US2433056A (en) * 1946-04-01 1947-12-23 Johnson & Johnson Method of producing sterile packages
US3411620A (en) * 1967-05-15 1968-11-19 Kendall & Co Combination catheter tray and package
US3528825A (en) * 1967-12-04 1970-09-15 Union Carbide Canada Ltd Shrink wrapped shirred casings
US3473646A (en) * 1968-04-12 1969-10-21 Burron Medical Prod Inc Syringe assembly
US3570485A (en) * 1968-05-06 1971-03-16 Baxter Laboratories Inc Flexible catheter and inserting apparatus
US3612038A (en) * 1969-02-03 1971-10-12 Becton Dickinson Co Preformable catheter package assembly and method of preforming
US3750875A (en) * 1971-06-04 1973-08-07 Affiliated Hospital Prod Packaged catheter arrangement
US3934721A (en) * 1971-06-04 1976-01-27 Affiliated Hospital Products, Inc. Packaged catheter arrangement
BE789131A (en) * 1971-09-24 1973-03-22 Extracorporeal Med Spec SURGICAL NEEDLE FOR PERFORMING MEDICAL OPERATIONS
US4033382A (en) * 1974-11-18 1977-07-05 Union Carbide Corporation Self-sustaining stick of shirred food casing
US4306562A (en) * 1978-12-01 1981-12-22 Cook, Inc. Tear apart cannula
US4424305A (en) * 1980-11-12 1984-01-03 Tyndale Plains-Hunter, Ltd. Surgical implants formed of polyurethane diacrylate compositions
US4412832A (en) * 1981-04-30 1983-11-01 Baxter Travenol Laboratories, Inc. Peelable catheter introduction device
US4411655A (en) * 1981-11-30 1983-10-25 Schreck David M Apparatus and method for percutaneous catheterization
SE445884B (en) * 1982-04-30 1986-07-28 Medinvent Sa DEVICE FOR IMPLANTATION OF A RODFORM PROTECTION
US4480642A (en) * 1982-07-26 1984-11-06 Health Products Research, Inc. Dilation device for the cervix
US4512338A (en) * 1983-01-25 1985-04-23 Balko Alexander B Process for restoring patency to body vessels
US4503569A (en) * 1983-03-03 1985-03-12 Dotter Charles T Transluminally placed expandable graft prosthesis
US4557385A (en) * 1984-02-23 1985-12-10 Union Camp Corporation Bag with easy open line of perforations
JPH0725973B2 (en) * 1984-04-28 1995-03-22 三菱レイヨン株式会社 Impact resistant thermoplastic resin composition
US4676773A (en) * 1984-08-13 1987-06-30 Kimberly-Clark Corporation Compact tampon tube applicator
US4911691A (en) * 1984-09-21 1990-03-27 Menlo Care, Inc. Assembly for adminstering IV solution
US4799479A (en) * 1984-10-24 1989-01-24 The Beth Israel Hospital Association Method and apparatus for angioplasty
CA1255640A (en) * 1985-02-26 1989-06-13 Kenji Nakamura Dispenser-container containing wet and dry contents and process for manufacturing the same
US4699611A (en) * 1985-04-19 1987-10-13 C. R. Bard, Inc. Biliary stent introducer
US4648867A (en) * 1985-07-03 1987-03-10 Henry Dreyfuss Associates Tampon system and method
US4690684A (en) * 1985-07-12 1987-09-01 C. R. Bard, Inc. Meltable stent for anastomosis
US4675008A (en) * 1985-10-04 1987-06-23 Tretbar Lawrence L T-tube
US4733665C2 (en) * 1985-11-07 2002-01-29 Expandable Grafts Partnership Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft
US4798876A (en) * 1985-11-12 1989-01-17 Tyndale Plains-Hunter Ltd. Hydrophilic polyurethane composition
DE3640745A1 (en) * 1985-11-30 1987-06-04 Ernst Peter Prof Dr M Strecker Catheter for producing or extending connections to or between body cavities
US4878906A (en) * 1986-03-25 1989-11-07 Servetus Partnership Endoprosthesis for repairing a damaged vessel
SE453258B (en) * 1986-04-21 1988-01-25 Medinvent Sa ELASTIC, SELF-EXPANDING PROTEST AND PROCEDURE FOR ITS MANUFACTURING
US4923061A (en) * 1986-07-30 1990-05-08 C. R. Bard, Inc. Catheter curve retention device
US4952359A (en) * 1987-02-06 1990-08-28 Becton, Dickinson And Company Method for making splittable catheter
US4772275A (en) * 1987-03-09 1988-09-20 Prn Services, Inc. Sheath for devices for injecting or withdrawing body fluids
US5041126A (en) * 1987-03-13 1991-08-20 Cook Incorporated Endovascular stent and delivery system
JPS6446477A (en) * 1987-08-13 1989-02-20 Terumo Corp Catheter
US5133732A (en) * 1987-10-19 1992-07-28 Medtronic, Inc. Intravascular stent
US4779727A (en) * 1987-11-25 1988-10-25 Mallinckrodt, Inc. Catheter packaging system
US4811847A (en) * 1988-03-14 1989-03-14 Reif Thomas H Urinary catheter package
US4925448A (en) * 1988-03-30 1990-05-15 The Cleveland Clinic Foundation Catheter package
US4878903A (en) * 1988-04-15 1989-11-07 Mueller Louis H Prefilled catheter tip syringe kit
US4994047A (en) * 1988-05-06 1991-02-19 Menlo Care, Inc. Multi-layer cannula structure
US5092877A (en) * 1988-09-01 1992-03-03 Corvita Corporation Radially expandable endoprosthesis
US4950257A (en) * 1988-09-15 1990-08-21 Mallinckrodt, Inc. Catheter introducer with flexible tip
US5067612A (en) * 1989-01-26 1991-11-26 Honshu Sangyou Kabushiki Kaisha Shrink film package having perforated folded strip
US4877132A (en) * 1989-03-20 1989-10-31 Luke Makris Syringe protection device
EP0408245B1 (en) * 1989-07-13 1994-03-02 American Medical Systems, Inc. Stent placement instrument
DE69010824T2 (en) * 1989-10-16 1994-11-24 Cordis Europ Packaging.
US5176617A (en) * 1989-12-11 1993-01-05 Medical Innovative Technologies R & D Limited Partnership Use of a stent with the capability to inhibit malignant growth in a vessel such as a biliary duct
US5041093A (en) * 1990-01-31 1991-08-20 Boston Scientific Corp. Catheter with foraminous anchor
US5048684A (en) * 1990-02-01 1991-09-17 Becton, Dickinson And Company Compact syringe and catheter package
ATE120377T1 (en) * 1990-02-08 1995-04-15 Howmedica INFLATABLE DILATATOR.
US5041085A (en) * 1990-02-26 1991-08-20 Cook Incorporated Percutaneous lockable sleeve catheter
US5071407A (en) * 1990-04-12 1991-12-10 Schneider (U.S.A.) Inc. Radially expandable fixation member
US5123917A (en) * 1990-04-27 1992-06-23 Lee Peter Y Expandable intraluminal vascular graft
US5078720A (en) * 1990-05-02 1992-01-07 American Medical Systems, Inc. Stent placement instrument and method
US5178611A (en) * 1991-05-01 1993-01-12 Paul Rosenberg Device and method for inhibiting intravascular device associated infection
US5131537A (en) * 1991-10-03 1992-07-21 Cordis Corporation Flexible tip tray packaging for medical catheters
US5282823A (en) * 1992-03-19 1994-02-01 Medtronic, Inc. Intravascular radially expandable stent
US5383928A (en) * 1992-06-10 1995-01-24 Emory University Stent sheath for local drug delivery
US5221263A (en) * 1992-07-30 1993-06-22 Gesco International, Inc. Catheter emplacement apparatus
US5282789A (en) * 1992-09-15 1994-02-01 Niemand Industries, Inc. Disposable medicine applicator
US5332092A (en) * 1993-02-16 1994-07-26 Ultradent Products, Inc. Protective syringe sheath and method of use
US5445646A (en) * 1993-10-22 1995-08-29 Scimed Lifesystems, Inc. Single layer hydraulic sheath stent delivery apparatus and method
US5389106A (en) * 1993-10-29 1995-02-14 Numed, Inc. Impermeable expandable intravascular stent
US5409469A (en) * 1993-11-04 1995-04-25 Medtronic, Inc. Introducer system having kink resistant splittable sheath
CA2213403C (en) * 1995-02-22 2007-01-16 Menlo Care, Inc. Covered expanding mesh stent

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4883699A (en) * 1984-09-21 1989-11-28 Menlo Care, Inc. Polymeric article having high tensile energy to break when hydrated
WO1990005554A2 (en) * 1988-11-07 1990-05-31 Boston Scientific Corporation Stent delivery system
US5089006A (en) * 1989-11-29 1992-02-18 Stiles Frank B Biological duct liner and installation catheter
US5139480A (en) * 1990-08-22 1992-08-18 Biotech Laboratories, Inc. Necking stents
WO1993006781A1 (en) * 1991-10-09 1993-04-15 Boston Scientific Corporation Impregnated stent
WO1994024961A1 (en) * 1993-04-23 1994-11-10 Schneider (Usa) Inc. Covered stent and stent delivery device
WO1995011055A1 (en) * 1993-10-22 1995-04-27 Scimed Lifesystems, Inc. Improved stent delivery apparatus and method

Cited By (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8647458B2 (en) 1995-03-10 2014-02-11 Bard Peripheral Vascular, Inc. Methods for making a supported graft
US8337650B2 (en) 1995-03-10 2012-12-25 Bard Peripheral Vascular, Inc. Methods for making a supported graft
US8617441B2 (en) 1995-03-10 2013-12-31 Bard Peripheral Vascular, Inc. Methods for making an encapsulated stent
US5928279A (en) * 1996-07-03 1999-07-27 Baxter International Inc. Stented, radially expandable, tubular PTFE grafts
WO1998000090A3 (en) * 1996-07-03 1998-01-08 Baxter Int Stented, radially expandable, tubular PTFE grafts
US6786920B2 (en) 1996-07-03 2004-09-07 Edwards Lifesciences Corporation Radially expandable stented tubular PTFE grafts
US6325819B1 (en) 1996-08-19 2001-12-04 Cook Incorporated Endovascular prosthetic device, an endovascular graft prothesis with such a device, and a method for repairing an abdominal aortic aneurysm
WO1998007389A1 (en) * 1996-08-19 1998-02-26 Cook Incorporated Endovascular prosthetic device, and method of use
AU738826B2 (en) * 1996-08-19 2001-09-27 Cook Medical Technologies Llc Endovascular prosthetic device, and method of use
WO1998019636A2 (en) * 1996-11-07 1998-05-14 Vascular Science Inc. Medical grafting methods and apparatus
WO1998019629A3 (en) * 1996-11-07 1998-09-11 Vascular Science Inc Medical grafting connectors and fasteners
WO1998019636A3 (en) * 1996-11-07 1998-10-08 Vascular Science Inc Medical grafting methods and apparatus
WO1998019629A2 (en) * 1996-11-07 1998-05-14 Vascular Science Inc. Medical grafting connectors and fasteners
US6517575B1 (en) 1996-12-31 2003-02-11 Scimed Life Systems, Inc. Multilayer liquid absorption and deformation devices
WO1998029148A1 (en) * 1996-12-31 1998-07-09 Scimed Life Systems, Inc. Multilayer liquid absorption and deformation devices
US7850705B2 (en) 1997-04-23 2010-12-14 St. Jude Medical Atg, Inc. Medical grafting connectors and fasteners
US7211095B2 (en) 1997-04-23 2007-05-01 St. Jude Medical Atg, Inc. Medical grafting connectors and fasteners
US6702829B2 (en) 1997-04-23 2004-03-09 St. Jude Medical Atg, Inc. Medical grafting connectors and fasteners
US6036702A (en) * 1997-04-23 2000-03-14 Vascular Science Inc. Medical grafting connectors and fasteners
EP0895761A3 (en) * 1997-08-04 2000-09-20 Schneider (Usa) Inc. Balloon expandable braided stent with restraint
US6660015B1 (en) 1998-01-30 2003-12-09 St. Jude Medical Atg, Inc. Medical graft connector or plug structures, and methods of making and installing same
US6994713B2 (en) 1998-01-30 2006-02-07 St. Jude Medical Atg, Inc. Medical graft connector or plug structures, and methods of making and installing same
US6387095B1 (en) 1998-02-09 2002-05-14 Loren R. Kennett Surgical device comprising a radially expandable non-conductive sheath
WO1999045852A3 (en) * 1998-03-09 1999-12-23 Corvascular Inc Anastomosis device and method
WO1999045861A1 (en) * 1998-03-09 1999-09-16 Biocompatibles Limited Urological stent
US6110188A (en) * 1998-03-09 2000-08-29 Corvascular, Inc. Anastomosis method
EP0941714A1 (en) * 1998-03-09 1999-09-15 Biocompatibles Limited Urological stent
US6241741B1 (en) 1998-03-09 2001-06-05 Corvascular Surgical Systems, Inc. Anastomosis device and method
WO2000002599A1 (en) * 1998-07-08 2000-01-20 Advanced Biocompatible Coatings Inc. Biocompatible metallic stents with hydroxy methacrylate coating
US6673084B1 (en) 1998-11-06 2004-01-06 St. Jude Medical Atg, Inc. Medical graft connector
US6620176B1 (en) 1998-11-06 2003-09-16 St. Jude Medical Atg, Inc. Medical graft connector and methods of making and installing same
US6599303B1 (en) 1998-11-06 2003-07-29 St. Jude Medical Atg, Inc. Medical graft connector and methods of making and installing same
US6533812B2 (en) 1998-11-06 2003-03-18 St. Jude Medical Atg, Inc. Medical anastomosis apparatus
US6508822B1 (en) 1998-11-06 2003-01-21 St. Jude Medical Atg, Inc. Medical graft assembly
US6113612A (en) * 1998-11-06 2000-09-05 St. Jude Medical Cardiovascular Group, Inc. Medical anastomosis apparatus
US8632555B2 (en) 1998-11-06 2014-01-21 St. Jude Medical, Cardiology Division, Inc. Medical graft connector and methods of making and installing same
US6152937A (en) * 1998-11-06 2000-11-28 St. Jude Medical Cardiovascular Group, Inc. Medical graft connector and methods of making and installing same
US6309416B1 (en) 1998-11-06 2001-10-30 St. Jude Medical Cardiovascular Group, Inc. Medical anastomosis apparatus
US6440163B1 (en) 1998-11-06 2002-08-27 St. Jude Medical Atg, Inc. Medical anastomosis apparatus
EP1140244B2 (en) 1998-12-23 2008-01-09 Atrium Medical Corporation Self-expanding prosthesis with biocompatible coating
US8617337B2 (en) 1999-02-02 2013-12-31 Bard Peripheral Vascular, Inc. Partial encapsulation of stents
US10213328B2 (en) 1999-02-02 2019-02-26 Bard Peripheral Vascular, Inc. Partial encapsulation of stents
US6712836B1 (en) 1999-05-13 2004-03-30 St. Jude Medical Atg, Inc. Apparatus and methods for closing septal defects and occluding blood flow
US6866674B2 (en) 1999-11-30 2005-03-15 St. Jude Medical Atg, Inc. Medical grafting methods and apparatus
US6602263B1 (en) 1999-11-30 2003-08-05 St. Jude Medical Atg, Inc. Medical grafting methods and apparatus
US7265199B2 (en) 2000-04-11 2007-09-04 Celonova Biosciences Germany Gmbh Poly-tri-fluoro-ethoxypolyphosphazene coverings and films
US7442205B2 (en) 2000-11-27 2008-10-28 Medtronic, Inc. Stents and methods for preparing stents from wires having hydrogel coating layers thereon
WO2002041931A3 (en) * 2000-11-27 2002-10-10 Medtronic Inc Stents and methods for preparing stents
US9080146B2 (en) 2001-01-11 2015-07-14 Celonova Biosciences, Inc. Substrates containing polyphosphazene as matrices and substrates containing polyphosphazene with a micro-structured surface
US8007821B2 (en) 2001-01-11 2011-08-30 Celonova Biosciences Germany Gmbh Substrates containing polyphosphazene as matrices and substrates containing polyphosphazene with microstructured surface
EP1262153A1 (en) * 2001-05-31 2002-12-04 Centrafid S.A. Stent for a vascular vessel
WO2002096319A3 (en) * 2001-05-31 2004-04-22 Centrafid S A Stent for a vascular vessel
WO2002096319A2 (en) * 2001-05-31 2002-12-05 Centrafid S.A. Stent for a vascular vessel
US7717937B2 (en) 2001-06-01 2010-05-18 St. Jude Medical, Cardiology Division, Inc. Closure devices, related delivery methods and tools, and related methods of use
US9078630B2 (en) 2001-06-01 2015-07-14 St. Jude Medical, Cardiology Division, Inc. Closure devices, related delivery methods and tools, and related methods of use
US8101275B2 (en) 2001-08-17 2012-01-24 Celonova Biosciences, Inc. Device based on nitinol, a process for its production, and its use
US7976564B2 (en) 2002-05-06 2011-07-12 St. Jude Medical, Cardiology Division, Inc. PFO closure devices and related methods of use
US7691128B2 (en) 2002-05-06 2010-04-06 St. Jude Medical, Cardiology Division, Inc. PFO closure devices and related methods of use
WO2004064894A3 (en) * 2003-01-15 2005-06-09 Scimed Life Systems Inc Intraluminally placeable textile catheter, drain and stent
US8574264B2 (en) 2003-04-11 2013-11-05 St. Jude Medical, Cardiology Division, Inc. Method for retrieving a closure device
US8372112B2 (en) 2003-04-11 2013-02-12 St. Jude Medical, Cardiology Division, Inc. Closure devices, related delivery methods, and related methods of use
US8114102B2 (en) 2003-06-16 2012-02-14 St. Jude Medical Atg, Inc. Temporary hemostatic plug apparatus and method of use
US9107850B2 (en) 2004-10-25 2015-08-18 Celonova Biosciences, Inc. Color-coded and sized loadable polymeric particles for therapeutic and/or diagnostic applications and methods of preparing and using the same
US9114162B2 (en) 2004-10-25 2015-08-25 Celonova Biosciences, Inc. Loadable polymeric particles for enhanced imaging in clinical applications and methods of preparing and using the same
US9597419B2 (en) 2004-10-25 2017-03-21 Boston Scientific Limited Loadable polymeric particles for enhanced imaging in clinical applications and methods of preparing and using the same
US10973770B2 (en) 2004-10-25 2021-04-13 Varian Medical Systems, Inc. Color-coded and sized loadable polymeric particles for therapeutic and/or diagnostic applications and methods of preparing and using the same
US7452372B2 (en) * 2005-09-22 2008-11-18 Boston Scientific Scimed, Inc. Bifurcated stent
US7922764B2 (en) 2006-10-10 2011-04-12 Celonova Bioscience, Inc. Bioprosthetic heart valve with polyphosphazene

Also Published As

Publication number Publication date
AU4929696A (en) 1996-09-11
US5674241A (en) 1997-10-07
US5968070A (en) 1999-10-19
AU719980B2 (en) 2000-05-18
CA2213403C (en) 2007-01-16
CA2213403A1 (en) 1996-08-29
WO1996025897A3 (en) 1996-11-21
EP0810845A2 (en) 1997-12-10

Similar Documents

Publication Publication Date Title
US5674241A (en) Covered expanding mesh stent
US5578075A (en) Minimally invasive bioactivated endoprosthesis for vessel repair
US5449382A (en) Minimally invasive bioactivated endoprosthesis for vessel repair
US6221091B1 (en) Coiled sheet valve, filter or occlusive device and methods of use
US6530947B1 (en) Stent delivery apparatus and method
EP0382014B1 (en) Intravascular endoprothesis
JP3361212B2 (en) Dual-stable luminal graft prosthesis
US6123720A (en) Stent delivery system with storage sleeve
EP0666066B1 (en) Bi-directional crimped graft
US5843161A (en) Endoprosthesis assembly for percutaneous deployment and method of deploying same
US6010530A (en) Self-expanding endoluminal prosthesis
US6146416A (en) Medical stents for body lumens exhibiting peristaltic motion
EP0689806B1 (en) Implantable tubular prosthesis having cuffs
US9327058B2 (en) Hydrogel enhanced medical devices
CA2174750A1 (en) Improved stent delivery apparatus and method
EP3076899B1 (en) Length extensible implantable device and methods for making such devices
JP2004517648A (en) Self-expanding stent with improved radial expandability and shape memory
WO2002089707A1 (en) Bioabsorbable stent-graft and covered stent
CA2470433A1 (en) Stent delivery apparatus and method
WO2001066167A2 (en) Large vessel stents and occluders
WO1999045861A1 (en) Urological stent
US20180071118A1 (en) Degradeable ostial stent
AU741137B2 (en) Covered expanding mesh stent
EP0928604A1 (en) Stent
JPH08229136A (en) Therapeutic apparatus for lumen organ

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU CA JP

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE

AK Designated states

Kind code of ref document: A3

Designated state(s): AU CA JP

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
ENP Entry into the national phase

Ref document number: 2213403

Country of ref document: CA

Ref country code: CA

Ref document number: 2213403

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 1996905567

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1996905567

Country of ref document: EP

WWR Wipo information: refused in national office

Ref document number: 1996905567

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1996905567

Country of ref document: EP